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 Objectives:  The purpose of this study is to advance the understanding of secondary 
conditions experienced by persons aging with the long-term disabilities of polio and rheumatoid 
arthritis and the consequences of these declines in health and function on disability bed days. 
Additionally, it explores the effects of the timing and severity of onset of disability 
characteristics on the frequency and consequences of secondary conditions. A life course 
conceptual framework with the Institute of Medicine’s model of disablement is used to frame 
and anchor disability and life events. 
 Methods:  In-depth structured in-home interviews were conducted on 216 individuals 
with polio and 186 individuals with rheumatoid arthritis.  They consisted of objective and 
subjective self-reports of current status and prior condition.  The survey was a regional cross-
sectional, group comparison design with a cross-sequential sampling and data analytic 
framework.  Scale development for data reduction was utilized to obtain parsimonious measures 
for the models.  Linear regression was then performed to test the models for three outcome 
variables (number of chronic secondary conditions, increases in functional limitations and 
number of disability bed days in six months) in a theorized order for the polio and RA samples 
individually.  
 Results:  There was partial support for within-sample hypotheses for both polio and 
rheumatoid arthritis regarding interrelationships and disability bed days in past six months.  No 
significant differences were found across subsamples for the effects of timing and severity of 
 
 
onset of disability characteristics, predicting chronic secondary conditions, predicting increase in 
functional limitations, and the number of disability bed days in six months. Similarities were 
found between the two samples when examining subgroup predictors on the three outcomes 
above.  Chronic secondary conditions predicted (p<.05 for both subsamples) increase in 
functional limitations and increase in mobility was a significant predictor (p<.001 for both 
subsamples) of increase in functional limitations.   
 Discussion:  There were limited findings for these data. Judgment must be withheld with 
respect to the hypotheses. The analyses did not yield enough predictive strength to make 
comparisons possible across subsamples. Likewise, in examining similarities, only general, 
descriptive statements could be made. The subjective nature of disability is an immense 
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Advancements in medicine, health care, rehabilitation and public health in our society 
have contributed to an increase in average life expectancy.  People are aging with long-term 
physical disability acquired earlier in life, and older persons who develop disability are living 
longer with their disabilities and are aging into disability. Life expectancy has increased.  Those 
who live to age 65 have an average life expectancy of an additional 19.2 years (20.4 years for 
females; 17.8 years for males) (Administration on Aging, 2011). Additionally, the number of 
persons aged 45-64 who will reach 65 within the next 20 years increased by 33% 
(Administration on Aging, 2011). In 2010, of the 303.9 million of the non-institutionalized 
population, approximately 56.7 million (18.7%) people had a disability and approximately 38.3 
million (12.6%) had a severe disability (Brault, 2012). The number of those disabled increased 
by 2.2 million from 54.4 million. Approximately 12.3 million people (4.4%) aged 6 years and 
older required assistance with at least one basic activity of daily living (BADL) or instrumental 
activity of daily living (IADL) (Brault, 2012).  
In previous eras, individuals with long-term moderate to severe disability did not survive 
long enough to be candidates for aging.  Now they are experiencing similar benefits in longevity 
as the rest of the population, yet their medical, psychological and social needs are less 
understood.   With this comes the paradox of longevity.  There are increased risks of new health-
related problems that come with longer life.  For these persons, the timing of these increased 
risks occurs earlier than is seen in the general population.  This premature onset has several 
implications:  health care resource implications, but also psychological and social implications.  
A population level (N=10,898) analysis (McColl, 2005) utilizing the Canadian National 
Population Health Survey compared disabled and non-disabled adults, aged 20 - 64, on health 
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and disability variables. The health and disability variables were not reported by age groupings, 
however, disability status by age was. When four categories comprising persons 45 – 64 years 
old are combined, the percentage of those nondisabled in the sample is the 34% compared to 
54% of those disabled. With respect to chronic conditions, 49% of the non-disabled had no 
chronic condition while 100% of the disabled population had at least one chronic condition. Ten 
percent of those who were nondisabled had three or more chronic conditions as compared to 
47% of those with a disability. Chronic conditions were not reported by age, but for the entire 
sample. Despite the fact that these data were from Canada, it nonetheless highlights the 
differences in the timing of the onset of increased disability conditions.   
Health for any given person is not static (Rimmer, 1999).  A person may be found on 
either end of the health spectrum (from low to high) at any given time depending upon any 
number of factors.  Rimmer (1999) uses the example of a person who at 40 has good health 
promotion practices and is at the high end of health but is then diagnosed with cancer.  During 
chemotherapy this person would be considered at the low end of the health spectrum.  Once 
treatment is finished, however, and healthy practices resume, health can shift back to the higher 
end of the spectrum.  Just as persons without long-term disability move in and out of health 
during their lives, so do persons with disability (Marge, 1999; Rimmer, 1999).   
However, individuals aging with long-term physical disabilities differ from the 
population at large in that their shifts in health status typically occur at younger ages and are 
preceded by or co-occur with significant increases in impairment related to the underlying 
disability and with declines in functioning. Post-polio syndrome provides a perfect example of 
moving in and out of health.  Many persons who experienced polio “recovered” to move on to 
lead healthy productive lives only to start experiencing a decline in their health later in their lives 
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that is due to their primary disability.  If the post-polio syndrome is managed well, health may be 
maximized within the context of their disability.  Rimmer, however, discusses disability only 
within the context of health promotion and does not make the distinction between health, 
impairment and function.   Simply stated, disability is the result of impairment and functional 
limitations originating from a primary disease or pathological process (Nagi, 1965) and these are 
not static. For instance, an individual with Rheumatoid Arthritis (RA) has periods of disease 
fluctuation that can result in an increase in impairment and often a decline in function, but can 
also experience a period of recovery where impairment declines and function improves.   Yet, 
despite this improvement, the overall trend of these individuals’ health declines.  This decline 
happens earlier thus putting them at risk earlier for the leading causes of death.  Rimmer (1999) 
also notes that the difference in the health shifts between those who have a long-term disability 
and others is that those with disability start at a lower position on the health spectrum and adds 
that secondary conditions intersecting with the primary disability is a primary reason for this.  
Additionally, those with disability are at higher risk for secondary conditions precisely because 
of their primary disability (Marge, 1999).    
 Campbell and Sheets (1998) compared a sample (N=555) of three age-matched cohorts 
who were aging with disability (post-polio, rheumatoid arthritis and stroke) to a national sample 
(Adams and Marano, 1995) and found that persons with long-term disabilities reported higher 
rates of almost all chronic conditions compared to same-age cohorts from the general population.  
Their data suggest that persons with early-onset of physical disabilities experience secondary 
health conditions which may put them at risk for “accelerated aging.”  They show that compared 
to same-age cohorts from the general population, persons with long-term disabilities report 
higher rates of almost all chronic conditions. This pattern is most pronounced in the 45 - 64 year 
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old cohort, where rates are two to ten times greater. They conclude that public health 
implications include providing health care professionals and disability advocates with 
information that can be useful in identifying low and high-risk groups, and in targeting 
prevention efforts more effectively.   The inclusion of “Disability and Secondary Conditions” as 
a Focus Area in Healthy People 2010 (U.S. Department of Health and Human Services, 2000) 
indicated the emerging importance of preventing secondary conditions among persons with 
disabilities of all ages. However, in Healthy People 2020 (NCHS, 2012), the Disability and 
Secondary Conditions Focus Area was expanded to increase the emphasis on health determinants 
and address a broader range of objectives.  The Focus Area’s name was changed to “Disability 
and Health,” thus diminishing the importance secondary conditions.  
 Policy initiatives such as the New Freedom Initiative (NFI) (2001) and the 
implementation of the Olmstead Decision (Olmstead v. L.C., 527 U.S. 581 [1999]) by the 
Olmstead Executive Order (13217, June 18, 2001) have increased attention to disability.  These 
two initiatives have placed tremendous emphasis on independent living and community 
integration, both public health related themes. The American with Disabilities Act (ADA, 1990) 
was referenced in both the NFI and the Olmstead Decision. The NFI’s key components are: 
increasing access to assistive and universally designed technology; expanding opportunities for 
those with disability to access to education; promoting full access to community life; increasing 
integration into the workforce; increasing access to transportation; and promoting 
homeownership. The Olmstead Decision by the U.S. Supreme Court compelled the federal 
government to fully enforce Title II of the ADA (U.S. Department of Justice, 1990; U.S. 
Department of Justice, http://www.ada.gov/olmstead/q&a_olmstead.pdf).  This meant that public 
 
5 
entities must avoid disability-based discrimination and provide to persons with disabilities 
community-based services if the services are appropriate and can be reasonably accommodated.  
 The most recent legislation to positively impact individuals with disabilities is the Patient 
Protection and Affordable Care Act (PPACA) signed into office on March 23rd of 2010 by 
President Obama (PPACA, 2010). It mandates and provides incentives to: 1) expand home or 
community-based care and directly cites the Olmstead Decision; 2) remove barriers and improve 
access to wellness for persons with disabilities; 3) eliminate discrimination against individuals 
because of age, disabilities or life expectancy with regard to coverage or reimbursement; and 
develop a healthcare workforce versed in cultural competency, prevention and public health.  On 
a more macro level, the PPACA includes programs that balances types of care, establishes a 
single point of entry, and improves coordination and transitions between care settings, all of 
which greatly benefit individuals with disabilities, as well as all users (Reinhard, Kassner and 
Houser, 2011).  
A. Statement of the Problem 
 
Because persons with disability have been under represented in national surveys and the 
data that have been collected across surveys are not comparable, it has been difficult estimating 
the number of persons aging with long-term disability (Campbell, Sheets and Strong, 1999).  
Additionally, better questions, such as age at onset and duration of primary disability, need to be 
asked.  It is therefore difficult to estimate the costs to individuals and to society that are 
associated with secondary health conditions.  There are direct and indirect economic costs such 
as medical dollars associated with the need for increased health care services, the inability for 
persons to engage in gainful employment, and the need for increased level of assistance.  There 
are also social costs such as the decrease of quality of life for individuals and their families.  
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Identifying risk factors for secondary health conditions will assist in determining how best to 
reduce the overall risk for age-related chronic conditions and thus reduce economic costs and 
increase quality of life for individuals aging with long-term disability.   
Before risk factors can be adequately assessed, secondary conditions have to be better 
defined and understood. Verbrugge, Merrill and Liu (1999) discuss the continually expanding 
survey questions used to measure disability and call for a global disability item similar to 
morbidity’s self-rated health in an effort to be parsimonious in measuring disability. Not having 
a widely accepted definition limits the ability of researchers to compare results and compile data 
sets for techniques such as meta-analysis. Determining key indicators of the components that 
comprise secondary conditions will also assist in creating more parsimonious models even if one 
global measure cannot be defined. 
 Past analyses using disability populations have utilized univariate and bivariate 
approaches. The literature has largely focused on conceptual refinement. Interrelationships of 
secondary conditions have not been examined with respect to how they work together to effect 
some policy related variable or health outcome.  
B. Study Goals 
 
This study is a methodological investigation to advance the understanding of 
interrelationships among hypothesized declines in health and function experienced by persons 
aging with the long-term disabilities of polio and rheumatoid arthritis. It will explore the effects 
of the trajectory of unique disability characteristics on the frequency and consequences of 
declines in health and function, examine the consequences of these declines in health and 
function on a health policy outcome, and finally compare distinctive disability characteristics 
between polio and rheumatoid arthritis on the trajectories of health and decline in function.  
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Independent of any hypotheses is another objective, which is to develop and test 
measurement models. Multiple indicator latent variables are constructed the major components 
of the chronic secondary conditions construct for persons aging with disability: 1) onset of new 
or increased disability-related symptoms; 2) onset of new declines in functional status; and 3) 
onset of chronic secondary conditions. The interrelationships among these measures are then 
examined. 
 Four goals are presented to address the measurement and understanding of secondary 
conditions across polio and rheumatoid arthritis. 
1. Advance the understanding of interrelationships among the components of secondary 
conditions for polio and rheumatoid arthritis; 
2. Explore how the unique disability characteristics of polio and rheumatoid arthritis 
with respect to severity at onset and temporal disability may be linked to differences 
in secondary conditions; 
3. Advance the understanding of the consequences of secondary conditions on disability 
bed days for individuals aging with long-term disabilities of polio and rheumatoid 
arthritis; and 
4. Compare potential subgroup differences between individuals aging with polio and 
rheumatoid arthritis in central indicators of each secondary condition component.
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II. LITERATURE REVIEW 
 A. Disablement 
 
 Disablement is a process of change.  Understanding disability, its complexities, and its 
impact at the individual and societal levels is a challenge. Since Nagi (1965) first proposed his 
framework of disability in an effort to define and conceptualize disability, it has endured several 
decades and is the basis for the models described below.  The concept of disablement describes a 
pathway with several domains from pathology to disability. Although these labels have evolved 
and in some cases, have been changed considerably, Nagi’s basic model has endured. This 
pathway is the result of a process that involves biological, environmental (social and physical), 
and lifestyle and behavior risk factors. Each point in the progression along the pathway can be 
influenced by these risk factors. The extent of disability and how it is experienced is the result of 
susceptibility due to these risk factors.   
 The basis for the model presented in this dissertation is that of Nagi’s (1965) and the 
IOM’s (1991). However, a review of the history of other primary models is useful as it illustrates 
the difficulties of developing a model that meets, at times, competing needs.  
1. The Nagi Model & The Institute of Medicine 
 
 The concepts in Nagi’s (1965) scheme, active pathology, impairment, functional 
limitation, and disability were similar to the ICIDH, however, there was no parallel to the ICIDH 
“handicap” concept because of Nagi’s sociomedical framework (Verbrugge and Jette, 1994). 
Verbrugge and Jette (1994) emphasize the intellectual scope and adaptability of Nagi’s scheme.  
This scheme consisted of 1) active pathology, the origin and defined as an interference of normal 
processes resulting from infection, trauma, metabolic imbalance, degenerative disease or other 
etiology and the concomitant efforts to normalize; 2) impairment defined as anatomical, 
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physiological, mental, or emotional abnormalities or loss; 3) functional limitation defined as 
limitation in performance of the individual due to the effects of impairment; and 4) disability 
defined as limitation in performance of socially defined roles and tasks within a sociocultural and 
physical environment. The IOM (1991) adopted the Nagi model with revisions by Nagi himself 
(1991), adding risk factors that occur both within the individual, and in the physical and social 
environment.  It was again revised (IOM, 1997) in 1997 to expand on environmental factors and 
add quality of life. 
2. International Classification of Impairments, Disease, and 
  Handicaps  
 
 The International Classification if Impairments, Disease, and Handicaps (ICIDH, 1980) 
was a taxonomy of disease impacts with three central concepts, impairment, disability, and 
handicap, that were tied to the International Classification of Diseases (ICD, 1986) used in 
medicine and health statistics. Disease was the origin of the model. Three levels of performance 
were then described that were conceptually distinct. Impairment corresponded to organ-level 
performance and defined as loss or abnormality of psychological, physiological, or anatomical 
structure or function.  Disability corresponded to person-level performance and was defined as a 
restriction of lack of ability to perform an activity in a normal manner.  Handicap was defined as 
disadvantage due to impairment or disability that limits or prevents fulfillment of a person’s 
normal role (depending upon age, sex, sociocultural factors) and corresponded to societal level 
performance. Controversy arose with the use of “handicap” and also neglecting to consider 
environmental factors (Whiteneck, 2007). As a result, a modified model, International 




3. The Disablement Process 
 
 Verbrugge and Jette, (1994) described “The Disablement Process,” a sociomedical model 
of disability built on Nagi’s (1965) conceptual scheme of disability and to a lesser extent, the 
International Classification if Impairments, Disease, and Handicaps (ICIDH, 1980). The 
components of Verbrugge and Jette ‘s disablement process expanded upon Nagi’s model by 
accounting for behaviors that increase risk factors or buffers to functional limitations and 
disability. These factors are extra-individual and intra-individual. Extra-individual factors 
include medical care and rehabilitation; medications and other therapeutic regimens 
(biofeedback/meditation, etc.); external supports; and built, physical, and social environment. 
The intra-individual factors include lifestyle and behavior changes (overt changes to alter disease 
activity); psychosocial attributes and coping (prayer, peer support groups, locus of control, etc.); 
and activity accommodations.  
 An important aspect of this model is the recognition that these factors may operate along 
the disablement trajectory at any point. Additionally, it allows for other outcomes such as quality 
of life (placed after disability), and “feedback loops” for secondary conditions and dysfunctions 
within a disablement process or new disablement processes. Verbrugge and Jette (1994) discuss 
the actuality that disability is a gap between person and environment.  Furthermore, a key 
element of the disablement process is the malleability of demand and reducing that demand by 
activity accommodations, environmental modifications, psychosocial coping, and external 
supports. 
4. The International Classification of Function, Disease, and Health 
 
 Verbrugge and Jette, (1994) described “The Disablement Process,” a sociomedical model 
of disability built on Nagi’s (1965) conceptual scheme of disability and to a lesser extent, the 
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International Classification if Impairments, Disease, and Handicaps (ICIDH, 1980). The 
components of Verbrugge and Jette ‘s disablement process expanded upon Nagi’s model by 
accounting for behaviors that increase risk factors or buffers to functional limitations and 
disability. These factors are extra-individual and intra-individual. Extra-individual factors 
include medical care and rehabilitation; medications and other therapeutic regimens 
(biofeedback/meditation, etc.); external supports; and built, physical, and social environment. 
The intra-individual factors include lifestyle and behavior changes (overt changes to alter disease 
activity); psychosocial attributes and coping (prayer, peer support groups, locus of control, etc.); 
and activity accommodations.  
 An important aspect of this model is the recognition that these factors may operate along 
the disablement trajectory at any point. Additionally, it allows for other outcomes such as quality 
of life (placed after disability), and “feedback loops” for secondary conditions and dysfunctions 
within a disablement process or new disablement processes. Verbrugge and Jette (1994) discuss 
the actuality that disability is a gap between person and environment.  Furthermore, a key 
element of the disablement process is the malleability of demand and reducing that demand by 




B. Aging with Disability 
 
Aging is a lifelong developmental process that starts at birth. For most aspects of aging, 
chronological age is a poor measure (Sheets, 2010). Disability may occur at any point along the 
developmental aging process. Those who are disabled experience aging with disability, while 
those who are aging experience disability with aging. Aging with disability is increasingly 
recognized as an important and challenging area to study. Until recently, individuals aging with a 
disability have not enjoyed the same life expectancy as their non-disabled peers. Advances in 
medicine and rehabilitation have made it possible for many with long-term disabilities to live 
into later life. As a result, the onset of secondary conditions (complications to the primary 
disability) is experienced earlier than those who are aging into disability and contributes to an 
accelerated aging (Campbell, 1997).   
Persons with lifelong disability do not always have the same opportunities with respect to 
skills, activities and life experiences (Verbrugge and Jette, 1994) as those who are experiencing 
disability with aging. The disability with aging cohort experience disablement gradually and can 
work to restore capabilities they once had (Verbrugge and Jette, 1994). Thus, the individual 
aging with a life-long disability “looks” very different from the person who has developed 
disability with aging.  
While there is some overlap between these two disability groups, they are very different. 
Their languages and behaviors differ. Age composition, professional background of its members 
and the type of services utilized characterizes the disability community (Campbell, 1997). Those 
who are in the disability with aging cohort are 65 years old and older, are in the aging network 
and have a more recent onset of disability. Age at onset (birth to young middle-age vs. mid to 
later life), cause of disability (congenital & acute disease/injury vs. chronic health conditions), 
 
13 
group identification (disability culture vs. ill-health), consumer role (advocates vs. 
patients/recipients) and professionals involved in service delivery all differ (Campbell, 1997).  
Some collaboration between the two groups has existed in the scientific community, 
however, in the discipline of social service, disability and aging have been distinct (Verbrugge 
and Yang, 2002). The two groups have been shaped historically by policy.  Even as far back as 
the revolutionary war the government paid soldiers disability-related and old-age pensions 
(Putnam, 2007). Restricted perceptions have existed since this time. Disability programs are 
focused on education, employment and housing, where aging programs focus on social well-
being and disease management (Verbrugge and Yang, 2002). Campbell (1997) contrasts the 
policies that helped to shape these two groups. The efforts of the disability community’s political 
activism resulted in the amendment to the Rehabilitation Act in 1978 and passage of the 
Americans with Disabilities Act of 1990, which set standards for public and workplace 
accessibility, but no way to implement them. In the aging network, legislative action created the 
area agencies on aging to expand the social service programs under the Older American’s Act of 
1965. 
C. Secondary Conditions 
 
 Secondary conditions in persons aging with long-term disability constitute negative and 
costly consequences of the disablement process, which through interventions and treatment, can 
be prevented or reduced (Campbell, Sheets, Rhaney and Moulton, 1999). They can compromise 
function that can lead to a loss of independence, undermine economic self-sufficiency, contribute 
to “accelerated aging,” and increase utilization of health and long-term care services. What 
defines a primary condition or a secondary condition or a chronic condition or a comorbid 
condition can depend upon one’s disciplinary perspective.  
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 The concept of secondary conditions is a complex multidimensional construct. Marge 
(1988) was the first to name and define “secondary disabilities.” The Institute of Medicine (Pope 
and Tarlov, 1991) cited Marge’s work, however, it was reframed as “secondary conditions.” 
Currently, the term “secondary conditions” has no operational definition which functions as a 
gold standard (Campbell, Sheets and Strong, 1999; Wilber, Mitra, Walker, Allen, Meyers and 
Tupper, 2002; Nosek, Hughes, Petersen et al, 2006).  In the Institute of Medicine’s (Pope and 
Tarlov, 1991) model, secondary conditions are defined as “a condition that is causally related to 
a disabling condition (i.e., occurs as a result of the primary disabling condition) and that can be 
either a pathology, an impairment, a functional limitation, or an additional disability”....and 
“would not occur in the absence of the primary condition (p.214).”  This causal relationship that 
is discussed can be either direct or indirect.  In Healthy People 2010 (U.S. Department of Health 
and Human Services, 2000) secondary conditions is defined more broadly as “medical, social, 
emotional, family, or community problems that a person with a primary disabling condition 
likely experiences (p. 6-3). ” 
 The above definitions represent just two of the various definitions for secondary 
conditions that can be found in the disability and public health literature.  Other definitions 
include factors such as complications and injuries that occur after the onset of the primary 
disability, new and/or increased symptoms, impairments, functional limitations, limitations in 
ADLs and IADLs, and limitations in social roles (Campbell, 1999).  Wilber et al. (2002) cite the 
use of even broader definitions such as health-related economic consequences for the individuals 
and members of their families.  Campbell, Sheets, and Strong (1999) discuss, as a definition of 
secondary conditions found in the literature, the inclusion of age-related chronic conditions (also 
known as co-morbidities) that affect the general aging population, but may occur earlier and 
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more frequently for persons with physical disabilities because of a narrower margin of health 
(DeJong and Hughes, 1982). Presently, the term secondary condition lacks clarity. More research 
is needed to elucidate the causes and consequences of secondary conditions with respect to 
disablement (Jette, 2006). Secondary conditions for this present analysis will include symptoms, 
chronic conditions and functional limitations.  
1. Symptoms 
 Different disabilities have different symptoms; however, pain, fatigue and muscle 
weakness cuts across almost all disabilities. They are three of the most common symptoms 
experienced by persons aging with disability and should not be confused with normal aging. 
These symptoms, if not addressed, can result in further disability. Further and specific discussion 
with regard to these three universal symptoms can be found in the polio and rheumatoid arthritis 
sections. 
 Disability has been found to be a strong predictor of chronic pain (Kinne, 2004) and 
requires examination to identify its cause in an effort to preserve function and to prevent or delay 
further decline.  Fatigue is characterized by tiredness, loss of energy and inability to carryout 
everyday activities.  It is three times more frequent in persons aging with disability than with the 
general population (Thompson, 2004). Extreme fatigue and pain have been found to have an 
independent relationship to fair to poor health (Kinne, 2004). Cook, Molten and Jensen (2011) 
found in their study of persons aging with spinal cord injury, post-polio syndrome, multiple 
sclerosis, and muscular dystrophy, that the risk of fatigue is greater than those without a 
disability and it also increases with age compared to normative values.  Fatigue can impact all 
aspects of one’s life. It can interfere in functional activities, sleep, and contribute to depression 
for example. It is often not given credence by health care professionals because of confounding 
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variables such as lack of sleep and depression. Work simplification and energy conservation 
techniques can help to ameliorate fatigue.   
 Muscle weakness is characterized by diminished physical or muscle strength. It can be 
associated with muscle and joint pain, general deconditioning and sarcopenia. There is a feeling 
that extra effort is required to perform activities. Depending upon where the muscle weakness is, 
throughout the body or isolated to specific muscles, there are implications for limitations.  Upper 
extremity weakness can result in the loss of one’s ability to propel a wheelchair or perform 
activities of daily living such as dressing, bathing, and meal preparation. Lower extremity 
weakness can interfere in ambulatory activities. Exercise is valuable in promoting and 
maximizing overall health, but must be approached conservatively as too much exercise can be 
counterproductive and cause injury. 
2.  Chronic Conditions 
 Turk (2006) outlines the history of secondary conditions from concept to practice.  She 
identifies the key dimensions of secondary conditions and then places secondary conditions 
using the taxonomies of disabilities from rehabilitation science and clinical practice. These are 
“primary conditions,” “associated conditions,” “comorbidities,” “aging” and “health.” 
“Treatment complications” is another category added (Field and Jette, 2007) to this list.  Primary 
conditions are the fundamental sources of disability. Associated conditions are aspects of the 
pathology of the primary condition that are expected to occur. Turk (2006) uses as example the 
primary condition of cerebral palsy that has several expected (associated) conditions that may or 
may not occur and to varying degrees: seizures, spasticity (an aspect of upper motor neuron 
impairment) and cognitive impairment. Comorbidities are health conditions that are independent 
of the primary condition.  Aging occurs whether there is a primary condition or not, however, 
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problems associated with accelerated aging, such as early-onset deconditioning, can be 
considered secondary conditions (Turk, 2006). Similar to Rimmer (1999), Turk defines health as 
a continuum that is not the absence of impairment or disease, but is dependent upon management 
of chronic disease, maintaining function and preventing secondary conditions. Treatment 
complications result from treatment of the condition and not the condition itself and can be 
preventable (Field and Jette, 2007). An example would be a side effect of a medication used to 
treat the primary condition.  
 In the medical literature, treatment complications have been identified as comorbidites 
(NRAS, 2012). With respect to rheumatoid arthritis, two types of comorbidity are defined: those 
resulting directly from the disease and those resulting indirectly from treatments (NRAS, 2012). 
In a review of comorbidity measurement, de Groot, Beckerman, Lankhorst and Bouter (2003) 
acknowledge that there is no consensus with regard to the definition of comorbidity, but stipulate 
when an index (or primary) disease is required for conducting research.  In research on 
multimorbidity no index disease is used, however, comorbidity research requires that an index 
disease be used. They note that comorbidity can be either the consequence or cause of a primary 
disease and they may also share the same risk factors. 
 There is a general agreement that the common denominator across definitions is that 
secondary conditions occur after the onset of the primary disability and are directly or indirectly 
related to it (Ravesloot, Seekins & Walsh, 1997; Campbell, Sheets and Strong, 1999; Kinne, 
Patrick and Lochner Doyle, 2004; Turk, 2006; Rasch, Magder, Hochberg et al., 2008). 
Additionally, agreement exists with regard to factors that cause secondary conditions: overuse of 
a neuromuscular system weakened from the primary condition (Turk, Overeynder and Janicki, 
1995); under or misuse of the neuromuscular system due to problems with gait, immobility or 
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deconditioning for example (Krause, 1996); complications from the primary condition 
(Treischmann, 1987); poor coping strategies and lifestyle behaviors such as alcohol abuse, poor 
nutrition, smoking, etc.; and environmental and attitudinal barriers that result in limiting access 
to health promotion and social participation (Brandt and Pope, 1997). Research by Kinne (2008) 
and Nosek, Hughes, Petersen et al (2006) illustrates the differences in how secondary conditions 
are defined, nonetheless, they each provide evidence of the magnitude of these conditions. Kinne 
follows the International Classification of Functioning, Disability and Health (ICF) (WHO, 
2001) model and delineates between types of secondary conditions:  secondary medical problems, 
secondary impairments and secondary participation limitations.  Nosek, Hughes, Peterson et al 
eliminated conditions that resulted from or reflected their subjects’ interaction with their 
environment and focused on health outcomes.   
 A conceptual model of secondary conditions that incorporates the ICF is proposed by 
Rimmer, Chen and Hsieh (2011) for the purposes of promoting higher-quality research in 
secondary condition prevention among rehabilitation and public health researchers.  Before 
addressing their conceptual model, they propose a hierarchical set of criteria for defining a 
secondary condition and created a decision-making algorithm for identifying them. They then 
present a conceptual model of the onset, course, and outcomes of secondary conditions in people 
with disabilities. As complex as their overall model is, their algorithm for identifying secondary 
conditions and corresponding management spectrum (p. 1732), if adopted by enough researchers, 
would go a long way in uniformly identifying secondary conditions.  
 Ravesloot, Seekins and Walsh (1997) performed a structural analysis to determine how 
secondary conditions might group and if factors are related to various primary impairments. 
They found that primary impairments did not predicted specific factors of secondary conditions, 
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however, certain secondary conditions were evident across a variety of impairments. Kinne 
(2004), in a population based cross-sectional study, found that secondary conditions were 
common among adults with disabilities, and that disability was the strongest predictor of pain, 
weight problems, fatigue, problems getting around, falls and other injuries, sleep problems, 
muscle spasms, and bowel and bladder problems.  Nosek, Hughes, Peterson, Taylor et al (2006) 
found in a cross-sectional study of women who were primarily ethnic minorities, that secondary 
conditions in women with physical disabilities were more problematic than previously reported 
in the literature. 
 Chronic conditions is a term used primarily in medicine and health services research for 
the purposes of describing trends (Martin, Freedman, Schoeni and Andreski, 2010), patterns of 
utilization (Schneider, O’Donnell and Dean, 2009) and estimating chronic conditions (Freid, 
Bernstein and Bush, 2012), managing and preventing chronic disease (Martin, Freedman, 
Schoeni and Andreski, 2010), predicting health care needs (Wolff, Starfield and Anderson, 2002) 
and costs (Wolff, Starfield and Anderson, 2002; Schneider, O’Donnell and Dean, 2009; Lewin 
Group, 2010), and measuring quality of care (Iezzoni, 2010).  Chronic conditions are often 
analyzed with functional limitations for the impact it has at an individual as well as a societal 
level. It can be defined as comorbidity based on diagnostic codes (Wolff, Starfield and Anderson, 
2002).  It can also be defined simply as a condition that lasts more than12 months and results in 
functional limitations or requires ongoing care (Lewin Group, 2010) or as health problem that 
persists over time without cure and caused by an underlying disease (Iezzoni, 2010). Iezzoni 
(2010) provides a thorough discussion of the definitions of chronic conditions and disability. She 
identifies disease and disability as distinct concepts that often coexist. Disease frequently 
contributes to disability and disability can cause secondary conditions or new diseases.  This is 
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illustrated by her example of osteoarthritis impairing ambulation as a disease contributing to 
disability and spinal cord injury contributing to pressure ulcers as a disability causing secondary 
conditions or new diseases.  
 The term multiple chronic conditions (MCCs) is gaining traction among health care 
professionals and researchers as it recognizes that increasing numbers of the U.S. population 
have two or more chronic conditions (Iezzoni, 2010; Freid, Bernstein and Bush, 2012).  From 
2000 – 2010, Freid, Bernstein and Bush (2012) found an increase in the percentage of adults who 
had two or more of nine selected chronic conditions in both the 45 – 64 and 65+ cohorts. These 
findings held across gender, all racial and ethnic groups studied and most income groups. There 
has not been an explicit recognition that multiple chronic conditions pose an important additional 
complexity to our healthcare system (Parekh, Goodman, Gordon, Koh et al., 2011). The National 
Quality Forum’s final report (2012) for the MCCs Measurement Framework considered the 
difficulties of how MCCs are defined.  A broad definition cited is the presence of two or more 
conditions. The difficulty with this is that it potentially captures too large a population and does 
not consider complexity and interactions of MCCs, e.g., having chronic sinusitis and 
osteoarthritis of the knee versus rheumatoid arthritis and diabetes. The report also cites the 
Agency for Healthcare Research and Quality’s (AHRQ) definition as addressing the 
complexities and interactions, yet it leaves out health status considerations such as function and 
quality of life. As a result of these incomplete definitions, the MCCs Steering Committee has 
defined MCCs as “having two or more concurrent chronic conditions that collectively have an 
adverse effect on health status, function, or quality of life and that require complex healthcare 
management, decision-making, or coordination (p. 7-8).” This definition, gives substance to the 
complexity that MCCs bring to healthcare. 
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 The move from a single disease focus to a multiple disease focus is an inevitable one. 
Treating illnesses individually ignores the synergistic impact (Vogeli, Shields, Lee, Gibson et al., 
2007) of MCCs.  Furthermore, treatment guideline conflicts can easily arise resulting in potential 
harm (PFCD, 2013). Patients are managed with MCCs in an acute care delivery and financing 
system (Thorpe, 2013), yet there is little health policy research with regard to the complex 
challenges that these patients present (PFCD, 2013; NQF, 2012; PCORI, 2013). These 
challenges exist across the spectrum of health care and involve (Thorpe, 2013):  patient 
empowerment; evidence-based management including pay-for-performance; and effective 
models of care that encompass prevention, self-management, caregiving and care coordination, 
and workforce training. A further challenge is to recognize that whether they are named 
secondary conditions, chronic conditions, comorbidities or secondary chronic conditions, on a 
practical level, secondary chronic conditions are becoming more common across the entire 
lifespan.  It is important not to lose sight that there is an increasingly younger population that has 
a long-term primary disability that they will be aging with. Not only will they have secondary 
chronic conditions, they will develop additional conditions that they will have to live with earlier 
than they would have to without their primary disability. Thus as younger populations are living 
longer with disabilities that were once not survivable into an advanced age. The healthcare 
system needs to treat people with long-term chronic disability at all ages with the same basic 
framework that will take into consideration variations in age and disability.  
3. Functional Limitations and Functional Disability 
 
 Functional limitations are restrictions in an individual’s ability to perform tasks or 
activities. Following the IOM/Nagi disablement model, functional limitations are the results of 
impairment and in turn are a measure of disability.  It is important to note that not all impairment 
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leads to functional limitations and mild functional limitations may not lead to disability. In 
research, functional limitations have traditionally been measured by three components: basic 
activities of daily living (BADL), instrumental activities of daily living (IADL), and mobility. 
Items included in each component can vary, but are generally similar from study to study. There 
is disagreement in the literature as to whether these measures are hierarchically related (Spector 
and Fleishman, 1998; Thomas, Rockwood and McDowell, 1998). 
 BADL items are eating, dressing, bathing, transferring (from bed to chair), toileting, and 
grooming. IADL items can include meal preparation, shopping, chores/light housework, money 
management, medication management, and telephone use. Mobility, the ability to move from one 
point to another independently, is used as a component or can be placed under the BADL 
component.  Examples (Guralnik, 2011) of items that can assess mobility are unable to walk ½ 
mile or climb stairs (higher mobility disability), or unable to walk across a small room without 
help (severe mobility disability). Other mobility items found are getting around in the 
community, wheelchair use.  
 Measuring functional disability varies in approach depending upon the how BADLs and 
IADLs are combined (Spector and Fleishman, 1998). One very common approach is to use them 
as separate constructs.  A second approach is to only use the IADL measure for those without 
BADL disability thus creating one construct with a summary score from the two measures. A 
third approach, taken by Spector and Fleishman (1998), was to develop a functional disability 
score from both measures using factor analysis and item response theory (IRT). Their findings 
demonstrated that the two measures are not hierarchically related and a simple sum could be 
used to derive a measure of functional disability. Using Guttman scaling and IRT, LaPlante 
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(2010) found that an IADL/ADL scale measuring “need for help” is hierarchical, unidimensional, 
and unbiased for age as compared to the classic ADL measure. 
 There is also no agreement as to which items to include and in which measures if BADLs, 
IADLs, and mobility are used separately.  Often a respondent is asked for each component item 
if they have had difficulty performing the task in question and if so, how much difficulty. The 
items can then be used as a scale. Items have been asked dichotomously.  Mobility items also 
lend themselves well to being used as performance measures (Guralnik, 2011). 
D. Public Health’s Role in Disability 
 
 Public health grew out of an effort to reduce mortality and later to reduce morbidity, but 
has responded slowly to the health needs of the disabled population in part because disability 
outcomes are not as clearly defined as mortality and morbidity (Lollar and Crews, 2003). 
Furthermore, public health perspectives regarding disability have viewed disability as a “burden 
of disease” and a disparity in access to the environment Krahn, Putnam, Drum and Powers, 
2006). Research and interventions are population based with measures focusing on morbidity, 
mortality, and quality of life. Intervention focuses on primary prevention and prevention of 
secondary conditions.  The contemporary perspective (Krahn and Campbell, 2011) is that 
persons with disability are a minority group at increased risk for poor health with the primary 
outcomes being health status and health related quality of life (HRQOL) that are influenced by 
disease that results in disability. Disability is a negative outcome and represents a failure to 
prevent an undesirable state (Crews and Lollar, 2006).  The emerging perspective (Krahn and 
Campbell, 2011) is where disability is viewed as one multiple determinants of health. Persons 
with disabilities are part of the general population and disability is just one of multiple risk 
factors for poor health. 
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Pope and Tarlov (1991) pointed to a first revolution in public health occurring with 
sanitation, basic nutritional needs, and immunization which resulted in 1) longer life expectancy, 
and 2) acute disease being joined with chronic disease as a focus of public health attention.  They 
emphasize the challenge of creating a second revolution that centers on lifestyle and behavior as 
primary components in health promotion and disease prevention.  They stress that traditional 
public health interventions have not had the same impact on chronic disease and its related 
disabling conditions.   
Just over ten years after Pope and Tarlov (1991) conclude that public health has fallen 
short of impacting chronic disease, Albert, Im and Raveis (2002) discuss, in their American 
Journal of Public Health (AJPH) editorial, “Public Health and the Second 50 Years of Life,” how 
little the discipline has promoted public health in people 65 years and older.  To illustrate this 
they randomly sampled nine of twelve issues of AJPH published in 2001 and counted original 
research articles that included people over 50 years of age.  Twenty-two percent of the articles 
addressed persons 50 years or older and many of those studies did not have study populations 
over 65 years of age.   
In the same editorial, Albert, Im and Raveis discuss three pathways to disability in aging 
and identify public health strategies to modifying those pathways.  In their model, a distinction is 
made between the physiological changes of aging that are not disease-based and lead to frailty 
and subsequent disability, comorbid conditions added to senescent changes that lead to disability, 
and the social and psychological environmental factors that result in disability.  They reference a 
study by Freid, Tangen, Walston, et al (2001) where 18% of the study population of 363 older 
adults had a disability that was likely the result of complex environmental, psychological and 
social factors. Albert, Im and Raveis recommend that the public health research community 
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direct more attention to the second 50 years of life and conclude that the AJPH is a good place to 
start.  Although not explicitly stated, there is an implication that people aging with a disability 
might be included in the category of requiring more direct attention in the next 50 years.   
Responding to this editorial, Crews and Smith (2003) specifically highlight the concept 
of aging with a disability.  They suggest that persons aging with a disability need to be included 
in the “second 50 years” and recommend that aging and disability need to be modeled together. 
They conclude that consideration should be given to specific disabilities when designing public 
health interventions directed at aspects of health such as secondary conditions.   
Illustrating how the disability and public health communities can build a future together, 
Rimmer (2011) explains how disability can be a component of each Section of the American 
Public Health Association.  Because disability cuts across every area of public health, having 
Disability Section members who are knowledgeable in a second content area belong to both 
Sections would facilitate communication between all the stakeholders.  Rimmer uses the 
Gerontological Health Section as an example and cites modern medicines advances leading to 
millions of adults who are aging with disabilities and facing secondary conditions as just one of 
risk factors that challenges successful aging.  Taking secondary conditions, he uses prevention 
and health management strategies to tie public health, aging with a disability and aging into 
disability together and thus the communities of each. 
 E. Disability Groups: Polio and Rheumatoid Arthritis 
 
 The two disability groups used in this analysis represent two very different disease 
courses as well as distinct ages at onset. Poliomyelitis is caused by a viral infection and has an 
acute onset with paralysis. Rheumatoid arthritis is a progressive systemic inflammatory disease 
that affects the joints of the body and can have a fluctuating disease process.   
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1. Poliomyelitis and Post-Polio Syndrome 
 
Poliomyelitis has been eradicated in much of the world. According to the Polio Global 
Eradication Initiative (http://www.polioeradication.org/), the last case of the wildpolio virus type 
3 (WPV3) strain of polio was reported in Asia occurred on the 18th of April 2012 in Pakistan. 
Nigeria, until very recently, was the only country worldwide that has reported a new case of 
WPV3 and that was on the 10th of November 2012.  The wildpolio virus type 2 (WPV2) strain 
was eradicated in 1999.  If there are no new cases of WPV3, it will be the second strain 
eradicated. Wildpolio virus type 1 (WPV1) remains with these cases located in third world 
countries. This strain had not been detected in the Syrian Arab Republic since 1999, however, 
due to civil conflict in the country, vaccination rates have fallen dramatically form 91% in 2010 
to 68% in 2012 resulting in ten confirmed cases on October 17 of this year.  These cases are of 
mostly children under two years old and there are more cases yet to be confirmed (World Health 
Organization, 2013).  
The development of the polio vaccine has lead to near eradication worldwide and is a 
remarkable achievement. However, there are an estimated 2.1 million Syrian refugees in five 
neighboring countries:  Lebanon, Jordan, Turkey, Iraq, and to a lesser extent, Egypt (Hummer, 
2013). The risk is considered to be high for the infection to spread to these neighboring countries 
and beyond  (World Health Organization, 2013).  With the refugee situation and an increasingly 
global mobile society, the success of near eradication is potentially jeopardized.   
The last case of polio was in 1979 (Centers for Disease Control, 2013).  Halstead (1987) 
estimated that there are 250,000 persons still alive in the United States who contracted paralytic 
polio before the vaccines were introduced in 1955.  If one includes both paralytic and non-
paralytic cases, there may be as many as 1.6 million survivors (National Center for Health 
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Statistics, 1989). The National Institute of Neurological Disorders and Stroke (2012) has slightly 
different figure and acknowledges that the incidence and prevalence of those with post-polio 
syndrome is not known as no survey has been conducted since the U.S. National Health 
Interview Survey in 1987.  They estimate that there are 443,000 paralytic polio survivors out of 
one million with about 25 – 40% having developed post-polio syndrome. 
 A phenomenon began emerging among polio survivors that was first identified in 1875 
by Raymond and Charcot (Dalakas, 1995) as “overuse.” This theory is still discussed today as 
the primary cause of post-polio syndrome (PPS).  Halstead (1992) established the term “post-
polio syndrome” and defined it as those persons who were symptomatic in regard to both new 
health problems and functional limitations.  PPS is characterized by new muscle weakness, 
muscle wasting, fatigue, and muscle or joint pain that result from an earlier episode of 
poliomyelitis (Halstead, 1988; Mulder, 1995; Dinsmore, 1998).  A diagnosis of PPS requires that 
an individual must report two or more of these symptoms and have a least one new activity of 
daily living (ADL) limitation.  These new symptoms typically appear about 25 to 40 years after 
infection (Grimby and Jonsson, 1994), however, the PPS diagnosis only requires a period of at 
least 15 years of neurologic and functional stability (Halstead and Rossi, 1987).  Additionally, no 
other medical diagnosis should explain the new health problems in order for the diagnosis of PPS 
to be used (Halstead and Rossi, 1987).  The diagnosis of PPS is one of exclusion where all other 
possible causes must be ruled out, thus making a diagnosis more challenging with possible 
coexisting conditions attributable to aging (Farbu, 2009). Late-onset sequelae of poliomyelitis 
(LOSP) is a term used to refer to new symptoms in a person who has polio, but does not meet the 




Wiechers, and Rossi (1985), and Halstead and Rossi (1988) found significant 
relationships between historical period and age at acute onset, and between age of onset and 
severity of initial impairment.  Fewer limbs were affected by weakness or paralysis if the polio 
was contracted before the age of 10 compared to those whose onset of polio was during 
adolescence or young adulthood.  Campbell (1994) found significant effects between age and 
historical period of acute onset in predicting both the severity of initial impairment and the 
presence of PPS.  Their data are consistent with prior studies (Dauer, 1955; Weinstein, Aycock, 
and Feemster, 1951; and Weinstein, 1957; Halstead, Wiechers and Rossi, 1985; Halstead and 
Rossi, 1988) and provides evidence that stage in the life cycle when polio was contracted and 
historical context impacts how impaired an individual was by the virus.  Their results show that 
as both the age at acute onset and the decade in which polio occurred increases, so does the 
percentage of the sample with 3 and 4 limbs affected (as opposed to 1 or 2 limbs).  Significant 
increases occurred for those who had polio at 10 years or older and who contracted it after 1940. 
There are three major symptoms associated with post-polio syndrome:  new muscle 
weakness, fatigue and pain.  The hallmark symptom of post-polio syndrome is new muscle 
weakness (Gawne and Halstead, 1995).  The pattern of new weakness, sometimes accompanied 
by atrophy, presents as slowly progressive, asymmetrical and scattered, occurring in either 
previously affected or muscles that were not affected during the acute episode (Jubelt and Agre, 
2000; Silver and Aiello, 2002; and Farbu, 2009), as well as those affected subclinically (Farbu, 
2009).  Additionally, increased activity results in exacerbation of the weakness by the end of the 
day (Silver and Aiello, 2002). Related to new weakness is the overuse of these abnormally 
fatigued muscles that require extensive rest to recover (Jubelt and Agre, 2000). Research with 
regard to functional muscle strength/new weakness is limited.  Nollet, Belen, Prins et al (1999) 
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looked at persons with and without PPS in a study of polio survivors with late-onset sequelae of 
poliomyelitis (LOSP) and found no difference between the two groups in manually tested 
strength, however, the PPS group required more time for performance testing and their perceived 
exertion was higher. Stolwijk-Swuste, Beelen, Lankorst, et al (2005), in a systematic review of 
the literature to identify prognostic factors associated with change in functional status and 
muscle strength, identified 19 studies related to these factors and found either insufficient quality 
or inconsistent results. 
Fatigue is the most frequent and debilitating symptom reported by people with PPS 
(Packer, Sauriol, and Brouwer, 1994; Nollet, Beelen, Prins et al, 1999; Jublet and Agre, 2000; 
Schanke and Stanghelle, 2001; Nollet, Beelen, Twisk et al, 2003; and Trojan and Cashman, 
2005).  It can lead to limitations in activities of daily living (ADL), social participation, and work 
duties (Packer, Sauriol, and Brouwer, 1994). Associations between fatigue and physical and 
psychological variables have been found by several investigators (Ostlund, Wahlin, Sunnerhagen 
et al, 2008; Trojan, Arnold, Shapiro et al, 2009; and Tersteeg, Koopman, Stolwijk-Swuste et al, 
2011). In their study, Trojan, Arnold, Shapiro et al (2009) conclude that PPS fatigue is complex 
and multidimensional, having three parts:  general, physical and mental.  Each of these parts is 
determined by different variables, some fixed (maximum inspiratory pressure, fibromyalgia, 
muscle strength, maximum expiratory pressure, age, time since acute polio) and others that are 
modifiable (stress, depression, physical activity, pain).   
Pain is a common primary symptom of PPS. The prevalence of muscle pain has been 
estimated to be 38% to 86% of patients and joint pain between 42% to 80% of patients. Jubelt 
and Agre (2000) aggregated data from three states. Muscle and joint pain were reported 
separately and were found to be similar. This held true for three of the four sites where the 
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percentages of those with muscle/joint pain were 94/94%, 74/72% and 73/73%.  The percentages 
at the fourth site were 68/61%.   
Researchers have shown an association between pain and fatigue (Vasiliadis, Collet, 
Shapiro et al, 2002; Trojan and Cashman, 2005; Stoelb, Carter, Abresch et al, 2008; Trojan, 
Arnold, Shapiro et al, 2009; Jensen, Alschuler, Smith et al, 2011; and Tersteeg, Koopman, 
Stolwijk-Swuste et al, 2011) and joint pain and muscle weakness (Vasiliadis, Collet, Shapiro et 
al, 2002). Pain can involve either muscles and/or joints (Jubelt and Agre, 2000; Trojan and 
Cashman, 2005; and Farbu, 2009). Stoelb, Carter, Aresch et al (2008) investigated pain with 
respect to frequency, intensity and impact. Ninety-one percent of their sample reported pain.  
Shoulders, lower back, legs and hips were where the most frequently reported sites.  Participants 
reported an average of 10 areas of pain, the most intense being found in the knees, legs, wrists, 
lower back and head. Sleep and activities involving a high level of musculoskeletal effort were 
affected most by pain. Finally, respondents’ pain problems were more severe compared with the 
general population. 
There is no single basis for muscle or joint pain (Halstead, 1987).  It can be the result of 
overuse (Halstead, 1987 and Farbu, 2009), disuse (Halstead, 1987) or compensatory use of 
unaffected muscles (Farbu, 2009). Vasiliadis, Collet, Shapiro et al, (2002) suggest that greater 
initial motor unit involvement and lower-extremity weakness may be important factors for 
determining joint pain. They investigated muscle and joint pain independently and found 
significant predictive factors for muscle pain were being female gender, longer duration of 
general fatigue and a lower score on the general health scale of the SF-36.  Joint pain factors 
were female gender, longer duration of stability after the acute onset, younger age at interview, 
greater weakness at acute polio, weaker lower-extremity muscle strength, and a lower general 
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score on the SF-36. Willen and Grimby (1998) reported physical activity in daily life as a 
correlate of pain.  Contradicting Willen and Grimby’s findings, Östlund, Wahlin, Sunnerhagen, 
and Borg (2008) found that low levels of activity and psychological functioning were correlates 
of pain.   
With respect to how those with PPS symptoms are aging, Stolwijk-Swiiste, Tersteeg, 
Beelen et al (2010), in a prospective study, examined the impact of age and comorbidity on late-
onset sequelae of poliomyelitis in a cohort of patients consisting of varying ages and levels of 
comorbidity. They found that disability increased little despite a sizable reduction in muscle 
strength. Interestingly, comorbidity and the extent of paresis negatively influence functional 
independence only, not perceived physical functioning.  They hypothesize that persons with 
LOSP may be able to maintain their physical functioning at the cost of their progressively 
weakening muscles, thus causing the symptoms of pain, fatigue and muscle weakness associated 
with post-polio syndrome. 
        2.  Rheumatoid Arthritis 
 Rheumatoid arthritis (RA) is a chronic syndrome that is a progressive, usually 
symmetrical, inflammatory disease resulting in peripheral joint and connective tissue damage 
(Berkow, 1991).  It can also affect multiple organ systems such as cardiovascular, renal and 
respiratory systems, and has an autoimmune component (Hootman, Helmick and Brady, 2012).  
Symptoms include joint pain and swelling, stiffness, fatigue, and deformity, and can lead to 
severe disability. Treatment includes medications, rest and exercise, and surgical procedures 
such as joint replacements and tendon transfers to correct joint damage.  RA affects individuals 
differently.  Symptoms vary considerably with three major disease progressions (CDC, 2012; 
Pincus and Callahan, 1993):  monocyclic (one major episode that lasts 2 – 5 years and does not 
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reoccur); polycyclic (fluctuating disease levels); and progressive RA (increases in severity and is 
unrelenting). Overall, the course of RA is highly unpredictable with exacerbations and 
remissions varying in length (Strating, Van Schuur and Suurmeijer, 2007). 
Gender and age are the epidemiological characteristics of RA (Mongan, 1990).  Although 
RA can occur at any age, including in children, onset is most frequently between the ages of 20 
and 40 with women being three times more likely to develop it as compared to men (CDC, 2012). 
Data from the Rochester Epidemiology Project (Myasoedova, Crowson, Kremers et al (2010) 
placed the incidence of diagnosed cases of RA at 41 per 100,000 each year from 1995-2007 with 
incidence rising with age (8.7 per 100,000 in the 18-34 age group versus 54 per 100,000 in the 
85 and older category). Incidence peaked in the 65-74 age group.  
Prevalence is estimated to be 1.5 million persons 18 and older (Helmick, Felson, 
Lawrence, 2008). The Rochester Epidemiology Project (Myasoedova, Crowson, Kremers et al, 
2010) calculated the overall age-adjusted prevalence for women in 1995 to be 7.7 per 1000 
versus 4.4 per 1000 for men.  In 2005, overall prevalence had risen for women to 9.8 per 1000, 
while it decreased slightly for men (4.1 per 1000 for men). 
Although the incidence of RA increases with age, the sex-ratio decreases in age.  The ≥ 
60 group with RA has a different sex-ratio. The female-male ratio decreases with greater age 
(Kvien, Uhlig, Odegard, Heiberg, 2006). Deal, Meenan, Goldenberg, Anderson et al (1985) 
compared clinical features of elderly-onset rheumatoid arthritis with younger-onset disease and 
found that age at onset was an important determinant of the disease course, adjusting for joint 
scores, disease duration, abrupt onset and polymyalgia rheumatica (often misdiagnosed as RA in 
those older than 60).  
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 The etiology of RA is not known and it is believed that in many cases there is an 
interaction between genetic factors and environmental exposures (CDC, 2012). Risk factors for 
RA fall into several categories:  socio-demographic, genetic, modifiable, and reproductive and 
breastfeeding history (CDC, 2012). As previously indicated, women are three times more likely 
than men to develop RA, and onset is highest for men and women in their sixties. Genetically, 
human leukocyte antigen (HLA) class II genotypes are associated with increased risk of RA 
(Scott, Wolfe and Huizinga, 2010). Conditions that are considered risk factors are: smoking, diet, 
reproductive hormonal exposures, and microbial exposures (CDC, 2012).  Research investigating 
the relationship between RA and smoking has demonstrated a strong, consistent link between the 
two, especially when have a marker of autoimmune activity (CDC, 2012). 
 With respect to reproductive and breastfeeding history, recent study results contradict 
earlier results and have found a lack of association between RA and oral contraceptives. There 
are mixed results for an association between RA and hormone replacement therapy and a slight 
to moderate increase in risk if a woman has never given birth (CDC, 2012). Breastfeeding has 
been found to be protective (Piker, Nilsson, Bergstrom et al, 2012). Finally, there have been 
mixed results concerning menstrual history. A study by Pikwer, Bergstrom, Nilsson et al., (2012) 
found an increased risk for RA in women who had early menopause (≤45 years of age). The 
same authors (Pikwer, Nilsson, Bergstrom et al, 2012) subsequently investigated severity of RA 
in association with menopause and found a milder form of RA in women who had early 
menopause (≤45 years of age) and whose disease onset was after the age of 45. 
 In an editorial, Sokka (2009) considers gender differences in persons with RA.  She 
discusses the results (Sokka, Kautiainen et al, 2007) of a large multinational dataset that utilized 
standardized quantitative instruments. This study found that women had poorer scores than men 
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in variables such as, but not limited to, number of tender joints, functional status, pain and 
fatigue. Effect sizes between genders were small to medium despite statistical significance. With 
respect to swollen joints, those who had none or one, women had higher mean values than men 
in all disease activity measures and experienced remission less often. Women and men had 
similar disease severity however, leading the authors to suggest that the measures of disease 
activity resulted in the gender differences instead of the disease activity itself (Sokka, Hetland, 
Makinen et al, 2008; Sokka, Toloza, Cutolo, et al, 2009).  A two year prospective study (Hallert, 
Thyberg, Hass, Skargren and Skogh, 2003) found women had more decline in functional ability, 
despite having similar scores as men on the disease variables.  The men were, on average, older 
than the women.  
 The major symptoms associated with RA are pain, fatigue and joint stiffness, resulting in 
functional limitations. The most acute of which is pain (Kazis, Meenan and Anderson, 1983; 
McKenna and Wright, 1985; Heiberg and Kvien, 2002; Minnock, FitzGerald and Bresnihan, 
2003). Pain is subjective. As Sokka (2005) observes, it is a personal experience that is 
underestimated by the traditional biomedical model.  Additionally, response to pain varies vastly, 
adding complexity for health care professionals in the treatment of pain (Kazis, Meenan and 
Anderson, 1983). A qualitative study (Ahlstrand, Bjork, Thyberg et al., 2012) utilizing focus 
groups recommends that “pain in RA needs to be comprehensively analyzed and treated in the 
context of the patients’ perspective and needs” (p. 1245). Pain is associated with health status 
(Kazis, Meenan and Anderson, 1983; James, Miller, Brown and Weaver, 2005), health behavior 
(Kazis, Meenan and Anderson, 1983), increased functional disability (Sokka, T., 2005; Strating, 
Van Schuur and Suurmeijer, 2007; Ahlstrand, Bjork, Thyberg, et al., 2012), psychological 
variables (James, Miller, Brown and Weaver, 2005; Sokka, T., 2005; Morris, Yelin, Wong and 
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Katz, 2008), longer disease duration (James, Miller, Brown and Weaver, 2005; Morris, Yelin, 
Wong and Katz, 2008), morning stiffness (Morris, Yelin, Wong and Katz, 2008); low self-
efficacy (James, Miller, Brown and Weaver, 2005; Sokka, 2005; Morris, Yelin, Wong and Katz, 
2008), and fatigue (Huyser, Parker, Thoreson, et al., 1998). 
 Although fatigue is one of the main complaints of rheumatoid arthritis, physicians do not 
show as much interest in treating it compared to other symptoms such as pain (Dupond, 2011). 
There is no clear definition because of its multidimensional nature.  Piper (1989) developed an 
integrative model that took into account many factors, both biologic and psychosocial, when 
considering subjective fatigue. Generally, fatigue is considered to have two components: 
physical and psychological (Huyser, Parker, Thoreson, et al., 1998). Physical fatigue can involve 
muscle weakness, tiredness, excessive energy expenditure, inadequate energy production, and 
sleep disorders (Dupond, 2011). In his review paper, Dupond, (2011) classifies psychological 
fatigue as weariness associated with depression and stress. Huyser, Parker, Thoreson, et al 
(1998) characterize subjective fatigue as a sense of extreme tiredness or exhaustion which 
encompasses psychosocial (e.g., depression, anxiety), behavioral (e.g., activity levels), and 
environmental (e.g., social supports) factors. In their study, fatigue was strongly associated with 
pain, depression, and other psychosocial variables. In an effort to determine whether 
conventional RA drug therapies reduce fatigue, Pollard, Choy, Gonzalez, et al (2006) 
investigated the relationship of fatigue to pain and other clinical features, and whether two types 
of drug therapies improved fatigue. They concluded that fatigue was linked to pain and 
depression, disease activity was secondary, and the success of drug therapies was the result of 
improvement in pain. Droegemuller, Brauer and Van Buskirk (2008), looked at the influence that 
temperament (positive affectivity, negative affectivity, constraint) has on fatigue and symptom 
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management strategies. They found that temperament was a significant factor in managing 
fatigue and additionally, older individuals were more successful in symptom management 
strategies.   
 While morning/joint stiffness is a major symptom of RA, studies taking into account 
symptoms have reported morning stiffness to be either not significant or less of a concern than 
pain and fatigue (McKenna and Wright, 1985; Hallet, Thyberg, Hass et al., 2003). There is little 
discussion about how morning stiffness fits into the scheme of the disease with regard to those 
quantitative studies that measure morning/joint stiffness. In a qualitative study, Lutze and 
Archenholtz (2007) were able to contextualize the impact morning stiffness has on daily routines 
using focus groups.  Even though morning stiffness may not be statistically significant (Hallet, 
Thyberg, Hass et al., 2003) or ranked lower in priority (McKenna and Wright, 1985) by subjects 
in quantitative studies, the authors show how impactful it can be in the daily lives of persons 
with RA. The American College of Rheumatology’s (ACR) 1987 criteria have been revised as 
they have poor sensitivity and specificity in diagnosing early inflammatory disease that goes on 
to become rheumatoid arthritis (Banal, Dougados, Combescure and Gossec, 2009). The revisions 
were made in conjunction with the European League Against Rheumatism (EULAR). A criterion 
in 1987 was “morning stiffness (at least 1 hour).” The new 2010 ACR/EULAR criteria (Aletaha, 
Neogi, Silman, Funovits et al, 2010) do not use morning stiffness as a criterion; instead the 
criterion is “duration of symptoms” and refers to pain, swelling or tenderness of joints. Morning 
stiffness has been removed. 
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III. CONCEPTUAL FRAMEWORK AND HYPOTHESES 
 
A. Life Course, Disability Trajectory and Disablement 
 
 A life course perspective helps to frame and anchor disability and life events. It illustrates 
the timing of age-related transitions and the timing and changes due to disability.  Conceptually, 
studying aging with disability requires integrating several theoretical approaches with measures 
of impairment and function from the fields of adult development, social gerontology, disability 
and rehabilitation (Campbell, 1994).  Campbell (1994) adapted Scheer and Luborky’s (1991) 
framework of the “disability trajectory” and incorporated the biopsychosocial model of 
rehabilitation (Kemp, Brummel-Smith and Ramsdell, 1990) with the life course perspective.  The 
conceptual framework for this dissertation applies this integrative approach to aging with 
disability utilizing the foundation of a life course perspective. Aging is viewed as a lifetime 
process where events that occur during one’s “younger” years can dramatically effect how one 
ages.  
The polio experience of the disability trajectory is used in Figure 1 to illustrate the 
conceptual life course framework of Campbell (1994). This conceptualization can be adapted for 
any disability where the “disability trajectory,” or timeline, and historical period will vary.  It 
highlights the complexities of aging with a disability by depicting the multiple variables that 
must be considered to clearly understand each disability’s unique characteristics, each 
individual’s unique situation in life, and how the two interact.   
There are two components of the horizontal axis.  The bottom represents the disability 
trajectory (Scheer and Luborsky, 1991), or timeline, from birth to death.  This is the temporal 
structure of disability-related events and takes into account onset of primary and secondary 
disability (Campbell, 1994).  The upper component of this axis represents chronological age 
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within the life span and is the most closely associated with physiological aspects of aging 
(Scheer and Luborsky, 1991).  The vertical axis represents the historical period in which an 
individual is born, acquires the disability, and ages (Scheer and Luborsky, 1991).  This axis is 
influenced by macro-level changes in societal attitudes and policies as well as advances in 
medicine and rehabilitation, all of which shape the context individual and social aging (Campbell, 
1994).  The diagonal axis is comprised of social aging and put into context within the life course 
stages or transitions from childhood to old age (Scheer and Luborsky, 1991).  Social aging 



































Underlying this conceptual framework is the Institute of Medicine’s (IOM) model of the 
disabling process (Pope and Tarlov, 1991) which builds on Nagi’s (1965) framework of 
pathology (stage 1), impairment (stage 2), functional limitation (stage 3) and disability (stage 4). 
Figure 2 shows the domains and items used in this analysis that are measured in each of the 
stages of the IOM model. Chronic conditions represent the secondary pathology in stage one.  
Severity of pain, fatigue, and muscle weakness for polio or joint stiffness for rheumatoid arthritis 
represent the impairment stage. The third stage, functional limitations, consists of items related 
to mobility. The final stage, disability, is represented by difficulties in instrumental activities of 
living (IADLs), such as getting around in the community, shopping, meal preparation, etc.  As 
discussed earlier, the IOM model does not specify a unilateral stepwise direction from pathology 
to disability. Although each stage in the disabling process usually occurs this way, an individual 
may skip over one of the stages (Pope and Tarlov, 1991). Each stage can be influenced by risk 
factors and quality of life. They also point out that the effects of any stage can be moderated by 
interventions such as assistive devices.   
The International Classification of Functioning, Disability and Health (ICF) (WHO, 
2001) model provides a comprehensive model of disability as discussed earlier. However, the 
conceptual aspects of the domains of activities and participation are problematic. In discussing 
the one-model fits all approach, Guralnik and Ferrucci (2009) point to sudden catastrophic 
disability in a younger individual where a disablement model might not be useful. Yet when 
disability is progressive, Nagi’s model is useful for identifying the stages over time and allowing 
for interventions along the pathway. Polio and rheumatoid arthritis are progressive diseases that 








 Aging with disability models correspond to both conceptual frameworks of life course 
perspective (processes of time that influence aging) and disablement (processes of change that 
contribute to secondary conditions and disability). The disability trajectory variables are the 
temporal anchors. They place the disability onset on the aging timeline. The increases in 
symptoms variables are disability-related secondary conditions and in effect, begin the active 
disablement process. Increase in mobility limitations, chronic secondary health conditions (due 
to aging and/or the primary disability), and increase in functional limitations (IADL) are all 
different components of secondary conditions. As discussed earlier, these pathways do not 
necessarily follow a prescribed course.   
 The concepts of the disability trajectory paired with chronological aging, historical period 
and life course framework are illustrated in Figure 1. Figure 2 places the components of the 
models into the framework of the disablement process. Figures 3 and 4 operationalize the 
relationships among the components for post-polio syndrome and rheumatoid arthritis 
respectively. Although the two models are very similar in structure, they differ in one very 
crucial respect.  Polio and rheumatoid arthritis have profoundly different disability trajectories 
that are reflected in the different variables in Figures 3 and 4. The trajectory variables anchor the 
disability at different life courses and are hypothesized to result in differences between polio and 
RA with respect to their disease courses.  Polio has an average age of childhood as an onset 
while RA has an onset of young middle age.  Both onset variables and status at physical best for 
polio and status at reference period are related to disease, but where RA is an intermittent 




Number of disability bed days (in six months) is the outcome for the fully specified 
models for polio and RA. Disability bed days is generally used in health care utilization research. 
Its utility is that it captures disability burden for both employed and unemployed individuals as 
opposed to work loss days that only capture disability burden for the employed (Egede, 2004). 
Disability bed days is a strong outcome measure in these data.  An earlier analysis (Campbell, 
Sheets, Rhaney and Moulton, 1999), analyzed data on a combined AwD sample of polio, RA and 
stroke.  It focused on four quality of life indicators: depressive symptoms, self-assessed health, 
number of physician visits in past year, and unmet need for services.  The analysis found that 
number of disability bed days was associated with lower quality of life of life across all four 
indicators (p<.001 each). 
Work status is included in the final model as a control for disability bed days. Table 5 in 
Methods contains the demographic differences between the polio and rheumatoid arthritis 
samples. Thirty-one percent of individuals with rheumatoid arthritis had never worked since 











C. Conceptual Models and Hypotheses  
Utilizing the integrated conceptual life course and disablement framework conceptualized 
in Figures 3 and 4, three hypotheses for each disability group were deduced which address 
interrelationships among the components of secondary conditions, explore the disability 
characteristics, and examine the effects of secondary conditions on disability bed days. An 
overall hypothesis compares secondary conditions between disability groups. The same general 
empirical pattern is deduced for the first three hypothesis, but disease-specific mechanisms are 
discussed that may give rise to secondary but important differences between the two. The overall 
hypothesized pathway examines predictors and outcome variable between the two disability 
groups.  
1. Polio Hypotheses 
 a. Interrelationships Among Components  
 
For those aging with polio, increases in mobility limitations will be more strongly related 
to increases in functional limitations than to the number of chronic secondary health 
conditions, controlling for demographic and disability characteristics. 
 
 Mobility limitations in polio are associated with severity of the initial onset of polio and 
the duration of the disease. Severity of initial onset increases risk for post-polio syndrome.  
Because of the neurodegenerative nature of post-polio syndrome, its characteristic new muscle 




 b. Unique Disability Characteristics 
 
For those aging with polio, disability trajectory indicators (severity of initial onset, 
duration of disability and status at physical best) will be more strongly related to 
increases in functional limitations than to the number of chronic secondary health 
conditions controlling for demographic characteristics for individuals aging with polio.  
 
 For individuals with polio, a more severe initial impairment at onset and longer disability 
duration contributes to mobility limitations that lead to faster deterioration in mid-life and in 
functional abilities. The initial impact of polio varied significantly for individuals and that has an 
impact on their longer-term functional outcomes.   
 c. Disability Bed Days  
For individuals with aging with polio, increases in symptoms (pain, fatigue, muscle 
weakness), increases in mobility limitations and increases in functional limitations will 
be stronger predictors of the number of disability bed days in the last six months than will 
the number of chronic secondary health conditions, controlling for demographic and 
disability characteristics.  
 
 Because of the neurodegenerative nature of post-polio syndrome, its characteristic new 
muscle weakness contributes to mobility and functional limitations. It is also characterized by 







 2. Rheumatoid Arthritis Hypotheses 
 
  a. Interrelationships Among Components  
 
For those aging with rheumatoid arthritis, increases in symptoms (fatigue, pain and joint 
stiffness) will be more strongly related to increases in functional limitations than to the 
number of chronic secondary health conditions, controlling for demographic and 
disability characteristics.  
 
 RA involves an autoimmune disease process that typically has a fluctuating disease 
course and variability in severity. It typically affects upper body joints (e.g. hands), causes pain, 
fatigue and joint stiffness. Increases in symptoms indicate that a more unstable disease process is 
occurring and therefore functional decline is related to activities that involve more upper body 
use. 
  b. Unique Disability Characteristics  
 
For those aging with rheumatoid arthritis, disability trajectory indicators (severity of 
initial onset, age at diagnosis and status at reference period) will be more strongly 
related to the number of chronic secondary health conditions than to increases in 
functional limitations controlling for demographic characteristics for individuals aging 
with rheumatoid arthritis. 
 
 Individuals with rheumatoid arthritis have a more a fluctuating disease course with 
variability in severity, which can depend upon severity of initial onset.  Those who are older 
when they develop it can have a more severe form.  The rheumatoid arthritis disease process 




joint replacement, the disability trajectory can be changed with restoration of function. A 
compromised immune system from the disease and pharmaceutical treatments will increase the 
risk of acquiring chronic secondary health conditions. 
  c. Disability Bed Days 
For individuals aging with rheumatoid arthritis, the number of chronic secondary health 
conditions will be a stronger predictor of the number of disability bed days in the last six 
months than will increases in symptoms (pain, fatigue, joint stiffness), increases in 
mobility limitations and increases in functional limitations, controlling for demographic 
and disability characteristics.   
 
Rheumatoid arthritis can affect multiple organ systems such as cardiovascular, renal and 
respiratory systems, and has an autoimmune component. Individuals with rheumatoid arthritis 
tend to have more treatment options available to them, including drug therapies and joint and 
tendon surgeries, thus, increases in symptoms, increases in mobility limitations and changes in 
functional limitations would not be as strong of a predictor of disability bed days as chronic 
secondary health conditions.  Drug therapies for rheumatoid arthritis are a double-edged sword. 
They can slow the disease progression, thus limiting declines in mobility and function, however 
they can have serious side effects that can contribute to chronic secondary health conditions.  
3. Comparison of Disability Group Differences  
 
Based on measures available for those aging with polio rheumatoid arthritis, 
relationships between predictors and outcomes (controlling for demographic variables) 
will not consistently be stronger for either disability group.  This hypothesis applies to 




predictors), increases in functional limitations (four predictors), and the number of 






A. Study Design For Secondary Data 
 
 Data for this secondary analysis are taken from the Aging with Disability (AwD) Study 
(Campbell and Sheets, 1996) conducted between 1996 and 1997 at the Rehabilitation Research 
and Training Center (RRTC) on Aging with Disability located at Rancho Los Amigos Medical 
Center in Downey, California.  The RRTC is also an affiliate of the University of Southern 
California.  The study was funded by the National Institute of Disability and Rehabilitation 
Research in the U.S. Department of Education.  It involved in-depth structured in-home 
interviews consisting of objective and subjective self-reports of current status and prior condition.  
The survey was a regional cross-sectional, group comparison design with a cross-sequential 
sampling and data analytic framework.  
 The AwD Study compared age-matched persons aging with early and later-life onset of 
disability in the areas of physical, psychological, and social status.  Data were collected from 555 
persons aging with polio, rheumatoid arthritis (RA) and stroke.  Research objectives were to 
determine if there were significant differences within and between disability groups with respect 
to health status; and to investigate how age, duration of disability, and other factors related to 
aging and disability influence these differences. For the purposes of this dissertation the stroke 
sample was not utilized.  Stroke often results in residual neurological impairment thus there were 
differences in how some of the questions for this analysis had to be asked.  A total of 404 cases 
(n=218 for polio and n=186 for rheumatoid arthritis) were used for this dissertation. 
1. Instrumentation 
 Data for the AwD study were collected using a comprehensive survey entitled “The 




and Sheets, 1996).  It was developed over a two-year period with considerable input from a ten 
member Consumer-Oriented Research Advisory Committee (CORAC) composed of persons 
with disability who were experts in their respective impairments.  
 The same survey instrument was administered to both the polio and RA groups to allow 
for comparisons across samples with the exception of a section that was specifically designed to 
address each particular disability.  The history of the disability component was adapted for each 
disability group to reflect the unique characteristics of the different disabilities.  Items in this 
section were carefully constructed to be able to make meaningful comparisons on similar items 
between disabilities.  Six major content areas were addressed:  history of disability; demographic 
characteristics; physical health status and services; functional ability, technology and 
accessibility; social issues; and psychological well-being/lifestyle practices. 
 It was anticipated that the survey would be comprised primarily of existing measures 
rather than having to develop a new instrument.  After systematically evaluating over one 
hundred scales and instruments from both the fields of gerontology and rehabilitation, Campbell 
and Sheets (1996) found that using existing measures was problematic due to the limited scope 
of cross-disability research.  Studies of change in the health and function of persons aging with 
disability are rare.  Ultimately, many of the questions in the AwD Survey were borrowed or 
modified from other studies.  The final survey was a combination of objective and subjective 
self-reports regarding prior and current health status that included selected scales and items from:  
1.  Basic and Instrumental Activities of Daily Living (National Health Interview 
Survey, 1994);  
2. Diagnoses/Chronic Health Conditions (National Health Interview Survey, 1994; 




3.  Functional Limitations (National Health Interview Survey, 1994);  
4.  Pain (Quantitative Pain Scale, SF-36 Medical Outcomes Study (Ware, 1992);  
5.  Fatigue (National Health Interview Survey, 1994; SF-36 Medical Outcomes Study 
- Ware, 1992);  
6.  Joint Stiffness (RADAR Scale, Mason et al., 1992); and  
7.  Severity of Impairment (National Health Interview Survey, 1994; Later Life 
Effects of Earlier Life-Disability Study, Campbell, 1994; Late Effects of Polio 
Study, Maynard et al., 1991)  
   One unique aspect to the AwD survey instrument is that it incorporates a disability 
perspective within a life course framework, thus taking into account temporal characteristics of 
the disability trajectory.   
 Cross-disability research faces many challenges in constructing variables that can 
compare over time changes in health status across disability (Campbell, Sheets, and Strong, 
1999).  To address some of these concerns, temporal indicators were established for each 
disability to reflect the varying nature of the disease course (Campbell & Sheets, 1996).  These 
temporal indicators illustrate the disability trajectory. With respect to the polio population, five 
reference points were established: onset of disabling condition; initial recovery/rehabilitation 
period; period of stability (“physical best”); onset of decline (beginning of changes in health and 
function); and current status as of time of interview.  For those who reported no “physical best,”  
“five years ago” was used as the reference point.  The conditions that occurred between the onset 
of decline and time of interview were considered secondary conditions.  The other temporal 




time of interview (duration of disability), and length of time between onset of decline and time of 
interview (duration of decline) were conceptualized as risk factors for secondary conditions. 
 Rheumatoid Arthritis required a different set of temporal indicators due to the fluctuating 
nature of the disease.  Three reference points were established:  age at diagnosis, an intermediate 
reference period, and time of interview.  With respect to the intermediate reference period, 
subjects were asked if they were in either a “good period,” remission, or a “bad period.”  A good 
period was defined as a stable period with mild disease activity.  Remission was defined as no 
disease activity, that is, an absence of arthritis pain and swelling.  A time of active exacerbated 
disease defined a bad period.  The reference period was considered the most recent change in 
disease activity.  Thus, if a subject were in a good period at time of interview, their reference 
period would be their most recent bad period.  If the subject were in a bad period, then their 
reference period would be their most recent remission or good period.  “Five years ago” was 
used if subjects did not feel that these reference periods were applicable.  (See Table 1.)  
Secondary conditions for the RA sample were defined as declines in health and function 
occurring between the reference period and time of interview.   Following the polio sample, the 
other temporal indicators were conceptualized as risk factors for secondary conditions, e.g., age 
at diagnosis and duration of disability. 
 
Table 1.  Establishment of Reference Period for Rheumatoid Arthritis Sample 
Rheumatoid Arthritis 
Intermediate Reference Period Time of Interview 
Bad Period Good Period 
 
Good Period Bad Period 
 
Good or Bad Period Remission 
 





2. Study Sample 
 The sample for the present secondary analysis consists of working-age and older adults 
living with the long-term effects of two disabling conditions:  polio and rheumatoid arthritis 
(RA). These two groups represent a natural examination in the life course differences between 
disabilities in which onset primarily occurs in childhood (i.e., polio; n=218) versus young to 
middle adulthood (i.e., rheumatoid arthritis; n=186). Subjects were randomly selected via a 
cross-sequential design from two subject pools: a county clinic-based outpatient population 
(from medical records); and a community-based pool (from disability organizations and support 
groups, and general solicitation).  A telephone screening was performed to confirm study 
eligibility and to collect personal background data. 
 Inclusion criteria for the subject pools varied by impairment group so as to capture 
epidemiological differences in disability trajectories.  For polio, these criteria included a credible 
history of paralytic polio contracted in the United States, a minimum age of 37, and a duration of 
disability of 20 years.  Rheumatoid arthritis criteria included a confirmed diagnosis, adult onset 
at 18 years or older, a minimum age of 30, and a post-diagnosis of 5 years.  All potential subjects 
had to be living in the United States at time of onset, have some residual physical impairment at 
time of measurement and live within one hour of the medical center.  See Table 2. 











Reliable history of paralytic polio 
 
Confirmed diagnosis for R.A. 
At least 20 years post acute onset 
 




Contracted polio in U.S. 
 
≥5 years post diagnosis 
 
 A clinic-based pool was created by reviewing medical records from 1989 to 1994 and 
coded for study criteria characteristics using a structured data collection protocol. The 
community-based pool was created by recruiting volunteers from disability support groups and 
organizations, physician referrals, radio public service announcements and word of mouth 
among consumers. The community-based pool was created to compensate for biases in the 
clinic-based population with the size varying based on biases in the demographic and disability 
characteristics of each clinic sample (Campbell and Sheets, 1996).  Table 3 is a summary of the 






     Table 3.  Overview of Sampling Framework and Achieved Sample 
Phase 1                                                   
Subject Recruitment  
                        Phase 2 








































(2,724) 455 736 404 
           1Number of waves sent out varied by sample: Polio = 11 waves; RA = 12 waves 
         (Source: M. Campbell, Aging with Disability Survey Study)  
 
 
Each disability has unique epidemiological characteristics, thus stratification was used in 
this cross-sequential sampling framework.  Both samples were stratified by chronological age to 
permit age comparisons. The unique Polio sample stratifying factors were gender and age of 
initial onset.  The Rheumatoid Arthritis sample was stratified by race/ethnicity and duration of 
disability.  As noted below in Table 4, RA has a disproportionate proportion of women because 





   Table 4.  Cross-sequential Sampling Design for Achieved Study Sample  
 Achieved Sample 
 
Polio Females Males 
<64 years, early onset ≤10 years 
 
20 36 
<64 years, later onset ≥11 years 
 
26 19 
≥65 years, early onset ≤10 years 
 
19 17 
≥65 years, early onset ≥11 years 
 
27 24 
TOTAL 122 96 
   
Rheumatoid Arthritis White Non-White 
<64 years, duration 5-19 years 
 
30 47 
<64 years, duration ≥20 years 
 
18 32 
≥65 years, duration 5-19 years 
 
10 8 
≥65 years, duration ≥20 years 
 
17 22 
TOTAL 75 109 
 
 
3. Sample Demographics 
 A summary of demographic characteristics appears in Table 5.  Significant differences 
are found between the Polio and Rheumatoid Arthritis samples in age, gender, ethnicity, 
education, household income and current work status.  Marital status had no significant 
differences.  The Polio sample was predominantly white (87%), was more likely to have at least 
a high school diploma (83% vs. 55% for RA), reported a higher income level (51% had an 
income level of greater than $35,000 vs. 39% for RA).  The Rheumatoid Arthritis sample was 
predominantly female (88% vs. 56% of Polio), Hispanic (47% vs. 5% of Polio), had less 
education (45% had less than a high school diploma), made less than $15,000 (34% for 
household income), and had never worked since disease onset (31% vs. 9% for Polio).  The 




The county clinic is located in LA County which, in 2000, was 45% Hispanic and in a city where 
58% of the population was Hispanic (City of Downey, 2000).   
 
































































≤ High School 
Some College 


























Current Work Status 
Working (Full or Part-time) 
Unemployed/Disabled 
Retired/Homemaker/Volunteer 
















4.  Data Collection 
 The interviews lasted from two to five hours, with most taking between two to three 
hours to conduct.  Because the RA sample was 48% Hispanic, two of the interviewers were 
bilingual in English and Spanish.  In the beginning of the interview, a “Participant Reminder 
Card” with important markers in the Polio and RA timelines was used so the respondent could 
refer to it during the interview.  These were used in part to improve the quality of the 
retrospective information. Participant reminder card can be found in Appendix I. 
B. Model Development for Present Analyses 
 
 Model development consisted of two parts:  scale development and model testing.   
The first step was to develop measurement models using factor analysis to test a parsimonious 
set of latent variables for the three constructs of secondary conditions that have been discussed in 
the literature for persons aging with disability:  1) increases in disability-related symptoms; 2) 
increases in functional limitations; and 3) onset of chronic secondary conditions. The second step 
was to use the latent variables estimated from step 1 in an overall theoretical model exploring the 
predictive relationships in the disability trajectory.  These can be found in Chapter III (Figures 3 
& 4) polio and rheumatoid arthritis models respectively.) A detailed description of each variable 
included from the AwD Survey Study can be found in Appendix II.   
1. Scale Development 
 Variables for increase in symptoms and increase in functional limitations were derived 
using change scores.  Change, or difference, scores were calculated using variables measured by 
having subjects refer to a specific point in time in their disability history that was consistent with 
the underlying nature of their impairment (Campbell et al, 1999).   This point in time is labeled 




subtracted from companion variables measured at time of interview.  These change variables 
were then used to derive three-level variables, mainly based on quantiles, for pain, fatigue, 
muscle weakness, joint stiffness, five basic activities of daily living (BADLs), five instrumental 
activities of daily living (IADLs), and six mobility variables.  Scales were then constructed from 
the change variables in each category.  This approach is utilized because the measures do not 
operate the same across the polio and RA groups (Campbell, 2012, email communication).   
Because of the nature of the disease, the RA group scores operate bi-directionally.  Some 
subjects improved, while others declined.  To use the traditional method of creating change 
scores after scales are constructed would eliminate the ability to compare the two populations as 
polio operates in one direction, showing decline (or as measured in these analyses, increase in 
symptoms and limitations).  A mathematical difference score would potentially not capture the 
fluctuating aspects of RA in a single variable that is comparable across two populations 
(Campbell, 2012, email communication).  Campbell et al (1999) have demonstrated the benefits 
in using change scores calculated in this way from these data. 
 Another issue is the significant variations in points in time which change was assessed.  
These varied significantly across the two impairment groups due to the differences in duration of 
disability and pace of change.  Maynard et al. (1991), have demonstrated the utility of using 
objective self-reports that are tied to well-recognized benchmarks, such as an established 
reference period. Verbrugge and Yang (2002) note that the dynamic processes of disability and 
aging are best studied with longitudinal data whereas cross-sectional data creates a disability 
profile that is the “residue of prior dynamics (p.254).”  However, she does support the use of 
cross-sectional data to study some aspects of the dynamic processes where questions have been 




 Analyses conducted by Campbell (2012, personal correspondence) using this AwD 
data have found that the greater the amount of change people experience in areas such as 
function and symptoms, the more psychological adjustment is required to incorporate disability 
into their identify. Significant change in physical functioning and symptoms also has major 
implications for participation in social roles such as employment, family, and valued activities.  
 Increases in symptoms represent secondary conditions that occur as a direct result of 
the primary disabilities of polio and RA.  Increases (change) in symptoms was measured on 
several three-level variables, calculated for pain, fatigue, muscle weakness (polio), and joint 
stiffness (rheumatoid arthritis).   
 Increases (change) in functional limitations originally had three domains with multiple 
variables in each.  The first, increases in basic activities of daily living (BADL) limitations, 
included five items that address self-care and include toileting, bathing, dressing, transferring 
and eating.  This domain was eliminated as the models were developed and will be discussed 
later in the paper.  Increases in instrumental activities of daily living (IADL) limitations is the 
second domain.  This consists of five variables that address more complex tasks such as 
shopping, meal preparation, medication management, etc.  The third and final domain, increases 
in mobility limitations, consists of six variables that represent aspects of community and 
residential ambulation, climbing stairs and wheelchair use.   
 Chronic secondary conditions was originally called age-related chronic conditions and 
initially had two domains:  mortality risk and morbidity.  Modification of this construct will be 
addressed later in the paper.  Mortality risk included nine diagnoses (cancer, COPD, kidney 
disease, liver disease, heart disease, hypertension, high cholesterol, diabetes, and stroke) of the 




(1994).  Eleven morbidity diagnoses (amputation, asthma, dental, fracture, glaucoma, low vision, 
obesity, osteoporosis, skin breakdown, stomach problems and thyroid disease), also selected 
from the NHIS as well as the Surveillance Instrument of Secondary Conditions (Seekins et al., 
1990), were included in the morbidity component of age-related chronic conditions.  Mortality 
risk diagnoses represented those diagnoses that were the leading indicators of mortality at the 
time of the survey.  Morbidity diagnoses were associated with chronic medical and physical 
conditions that represented complications of the primary disability and new onset of age-related 
diseases.   
  2. Predictive Model 
 The model for polio and rheumatoid arthritis is presented in Chapter 3 (Figure 3).  There 
are three outcome variables:  number of chronic secondary conditions, increases in functional 
limitations (IADL), and number of disability bed days in six months.  The demographic/control 
variables consist of age, gender and education.  Current work status is added to the demographic 
variables for the fully saturated model predicting number of disability bed days.  The disability 
trajectory variables consist of duration, severity at onset and status at physical best for the polio 
sample.  The RA sample trajectory variables are age at diagnosis, severity of onset and status at 
reference period.  Increases in symptoms dimension consists of pain, fatigue, muscle weakness 
(polio) and joint stiffness (RA).  
3. Final Analysis 
 Linear regression was performed to test the models for three outcome variables (number 
of chronic secondary conditions, increases in functional limitations and number of disability bed 




 Regression analysis tests theoretically driven hypotheses by entering several predictor 
variables in an ordered sequence to determine the relative importance of a predictor by 
examining the unique contribution a predictor adds to the model above and beyond what can be 
accounted for by the other predictors (Petrocelli, 2003).  The relationship between the predictor 
(or independent) variables on the dependent variable is evaluated by first entering control 
variables, followed by sets (or blocks) of predictor variables in a specified a priori order.  Taken 
into account is the impact of a different set of predictor variables on the dependent variable while 
controlling for all the other predictors in the equation. At each stage, an additional predictor 
variable or variables are added to the model and ∆R2 is calculated.  A null-hypothesis test is 
undertaken to test whether the ∆R2 is significantly different from zero. Of interest is the change 





V. RESULTS:  SCALE DEVELOPMENT 
 
A. Increases (Change) in Symptoms 
 
 Increase in symptoms was to be measured as one construct consisting of change, or 
difference, scores in self-reported pain, fatigue, muscle weakness (for the polio sample) and joint 
stiffness (for the RA sample). Since the increase in symptoms construct has only three variables 
in each subgroup, creation of an index was considered.  Correlations were calculated to 
determine if there was enough common variance to combine the three variables into a single 
dimension index. Correlations among these variables were low (see Tables 6 and 7 below) and 
Cronbach’s alphas (.490 for polio and .513 for RA) failed to meet the criterion for adequate 
internal consistency of .7 or greater. Thus these four variables (three for each sample) were 
treated as separate measures in the regression modeling. 
Table 6.   Correlation Matrix for Change in Symptoms Variables For Polio 
Sample (n=218) 
 Change in  
Muscle Weakness 
Change in 
Fatigue Change in Pain 
Change in Muscle 
Weakness 
1   
   
Change in Fatigue .224** 1  
   
Change in Pain .234** .268** 1 
   














B. Increases (Change) in Functional Limitations 
 Increase in functional limitations construct was to be measured by three components: 
BADLs, IADLs and Mobility. Higher-level latent variables were analyzed by principal 
components analysis (PCA) and Varimax rotation with Kaiser Normalization.   
1. Basic Activities of Daily Living 
 
 Five items were included in the basic activities of daily living component that measured 
change in bathing/showering, dressing/grooming, toileting, eating and transferring. Choice of 
these variables is informed by research studies in the field of health care and sociology (Katz, 
Ford, Moskowtiz, Jackson et al, 1963; Lawton and Brody, 1969; Kempen, Meyers and Powell, 
1995; Thomas, Rockwood and McDowell 1998; Kane and Kane, 2000; Roehrig, Hoeffken, 
Pientka and Wedding, 2007). It is widely accepted that these items form a single scale with 
satisfactory psychometric properties.    
 Polio One factor was extracted. The eigenvalue (i.e., the variance of a linear function of 
the variables) of this factor (2.697) accounts for 54% of the variance. Table 8 displays the 
component values.  A regression score was computed with the expectation that it would be used 
in the analysis. 
Table 7.   Correlation Matrix for Change in Symptoms Variables For 
Rheumatoid Arthritis     (n=186) 




Change in Pain 
Change in Joint Stiffness 1   
   
Change in Fatigue .261** 1  
   
Change in Pain .218** .460** 1 
   













Change in dressing/grooming 
Change in eating 
Change in toileting 
Change in transferring 
Extraction Method: Principal Component Analysis.  
 
 Rheumatoid Arthritis A single factor with an eigenvalue of 3.447 was extracted and 
accounted for 69% of the variance. See Table 9 for the loadings.  A single regression score was 
computed for expected use in the subsequent analysis. 
 




Change in bathing .888 
Change in dressing .874 
Change in eating .772 
Change in toileting .867 
Change in transferring .741 





2. Instrumental Activities of Daily Living 
 
 As with basic activities of daily living, IADLs are an important and widely used construct 
for measuring physical function. The items contained in this analysis are: change in ability to 
perform chores and/or light housework, meal preparation, medication management, use of the 
telephone, and shopping.   
Table 10.  Polio Sample Factor Loadings for IADLs 
 Component 
1 2 
Change in chores/light house work .795 .240 
Change in meal preparation .820 .023 
Change in medication management -.015 .914 
Change in use of phone .384 .598 
Change in ability to shop .838 .150 
Extraction Method: Principal Component Analysis. 
Rotation Method: Varimax with Kaiser Normalization. 
 
Table 11.  Polio Sample One Factor Solution for IADLs 
 Component 
1 
Change in chores/light house work .820 
Change in meal preparation .748 
Change in medication management .384 
Change in use of phone .606 
Change in ability to shop .820 
Extraction Method: Principal Component Analysis. 
 
 Polio The PCA extracted two factors.  Factor one, labeled “physical IADL” has an 
eigenvalue of 2.420 and explained 48% of the variance. These three items require greater 




“cognitive IADL” because of the two items’ heavier cognitive burden has an eigenvalue of 1.008 
and explains 20% of the variance.  Table 10 displays the loadings for the two components.  
 An additional variable has now been added with the two factor results when the goal is to 
produce parsimonious models.  More importantly, the RA sample loaded on one component (see 
Table 12 below) making it difficult to compare the two samples in the final analyses. Since the 
eigenvalue for factor two is 1.008, it just meets the criterion for extracting factors based on an 
eigenvalue of 1.000.  Therefore, a Cronbach’s alpha was calculated to determine whether these 
items would scale adequately.  Cronbach’s alpha was .723 making it an acceptable, if not optimal, 
option for a scale.  A decision was made to compute a regression score based on one factor.  
Table 11 shows" the one factor solution.   
 Rheumatoid Arthritis PCA extracted one factor with an eigenvalue of 3.245 that 
explained 65% of common variance. A single regression score was computed for use in the final 










 Six mobility items in the AwD Study were chosen to represent the many dimensions of 
moving, or “getting around,” as opposed to walking.  They are change in: getting around the 
Table 12.  RA Sample Factor Loadings for IADLs 
 Component 
1 
Change in chores/light house work .886 
Change in meal preparation .901 
Change in medication management .650 
Change in use of phone .706 
Change in ability to shop .852 




community; walking 2-3 blocks, getting around residence, walking across the room, climbing 10 
stairs, and wheelchair use. Walking refers to the physical ability of moving one’s lower 
extremities in a purposeful way. Walking is often used as a proxy for overall mobility (and thus 
for participation).  In fact, one does not have to physically walk to be mobile. A person who does 
not have the ability to adequately use his/her legs may be able to fully participate in desired 
activities by using a wheelchair or scooter. Further, one may have the ability to walk, but may be 
fearful of falling for instance, and thus limit walking and the ability to fully participate in 
activities.  
 Polio Using PCA, two factors were extracted.  Factor one, labeled “residential mobility,” 
had an eigenvalue of 3.393 and accounted for 55% of variance.  The second factor, labeled 
“community mobility,” had an eigenvalue of 1.155 and accounts for 19% of the variance.  See 
Table 13.  As with the IADL items, the rheumatoid arthritis sample yielded one factor (see Table 
15 below). Again, to reduce the number of variables, keep uniformity across samples and for 
conceptual reasons, a one-factor solution was desirable.  The mobility dimension was not 
conceived strictly as ambulation.  It is a continuum of mobility from residence to community and 
includes wheelchair as a mobility option.  Therefore, a Cronbach’s alpha was computed to 
determine if these items could be scaled together. Cronbach’s alpha was .841, which places the 
items as a scale in the good range.  A regression score was computed for inclusion in the final 








Change in W/C use  .708 .092 
Change in getting around in community .049 .920 
Change in walking 2 - 3 blocks  .289 .887 
Change in getting around residence  .856 .269 
Change in walking across room .906 .234 
Change in climbing 10 stairs  .479 .639 
Extraction Method: Principal Component Analysis.  
 Rotation Method: Varimax with Kaiser Normalization. 
 




Change in W/C use  .585 
Change in getting around in community .657 
Change in walking 2 - 3 blocks  .812 
Change in getting around residence  .813 
Change in walking across room .826 
Change in climbing 10 stairs .785 
Extraction Method: Principal Component Analysis.  
 
 
 Rheumatoid Arthritis One factor for the mobility items was extracted using PCA.  Sixty-
four percent of the variance was explained for an eigenvalue of 3.810 (Table 15). A regression 








Change in W/C use  .503 
Change in getting around in community .836 
Change in walking 2-3 blocks  .900 
Change in getting around residence  .800 
Change in walking across room  .823 
Change in climbing 10 stairs  .855 
Extraction Method: Principal Component Analysis.  
 
C. Number of Chronic Secondary Health Conditions 
 
 Originally, the construct of chronic secondary health conditions was conceptualized as a 
two-dimension construct, age-related chronic conditions.  As discussed previously, these 
dimensions were mortality and morbidity diagnoses. The items included in each construct were 
collected at time of interview and are not change variables.  Respondents were asked for each 
condition whether they had been diagnosed or treated for the condition by a doctor or other 
health care professional since the onset of their disability.  The variables are dichotomous:  yes 
or no.   
 For both mortality risk and morbidity, the combined samples of polio and rheumatoid 
arthritis were used to perform an exploratory factor analysis and derive scores for the purpose of 
data reduction.  The samples were combined because subgroup analyses revealed that there was 
not enough statistical power to be confident in the findings if they were to be analyzed and used 
separately. Correlations were conducted on the nine mortality risk and eleven morbidity 
diagnoses using the whole sample.  Low correlations prevented further analysis, specifically, 




25 & 26. As a result, mortality risk and morbidity diagnoses were combined and a summing 
strategy was employed.   
 The chronic secondary conditions variable was constructed by identifying dichotomous  
(yes/no) items from both the mortality risk and morbidity categories previously identified from 
the NHIS.  Three conditional items were constructed:  respiratory, arthritis, and gastrointestinal 
(GI). The respiratory item was given a “yes” score of 1 if a subject had emphysema/COPD 
and/or respiratory insufficiency.  Likewise, arthritis was given a “yes” score of 1 if the subject 
had osteoarthritis and/or osteoporosis.  Finally, the GI item was given a “yes” score of 1 if the 
subject had one or more of the following:  ulcer, gastritis, colitis, irritable bowel syndrome or 
“other GI diagnosis.” Other items in the chronic secondary conditions variable are:  heart 
diagnosis, hypertension, stroke, high cholesterol, diabetes, cancer, skin breakdown, glaucoma, 
low vision, hearing loss, thyroid disease, kidney disease, liver disease, asthma and obesity.  The 
above items were then summed.  
D. Changes in Model Based on Scale Development Results 
 
1. Increase in Functional Limitations 
 
 The construct of increase in functional limitations was broken apart. A decision was 
made to eliminate the BADL component.  First, difficulty with BADLs generally occurs after 
difficulties in IADLs are seen and represent a lower level of functioning (Kempen, 1995). Both 
Polio and Rheumatoid Arthritis samples were community-based and this population typically 
represents a higher level of functioning. Secondly, the variability in the items could have been 
more favorable. Table 16 provides the frequencies for the BADL items. Thirdly, eliminating a 




 Increase in mobility limitations was originally going to be analyzed with BADL and 
IADL. After dropping BADL, the order of mobility in the model was revisited and it’s placement 
was separated from IADL. While still a component of functional limitations it has been placed 
after increase in symptoms and before chronic secondary conditions.  This placement reflects the 
evidence that mobility is directly linked to disease characteristics, impairments and functional 







2. Chronic Secondary Conditions 
 
 As discussed above, chronic secondary conditions was originally called age-related 
chronic conditions and initially had two domains:  mortality risk and morbidity.  
The new variable was constructed by identifying chronic secondary conditions in current 
literature (The Lewin Group, 2010; Freid, Bernstein and Bush, 2012; Martin, Freedman, Schoeni 
et al., 2008; Schneider, O’Donnell and Dean, 2009). The name of the construct was changed 
from age-related chronic conditions to acknowledge secondary conditions’ presence in the public 
health literature.  An additional benefit of having one variable is that it supports a more 
parsimonious model.  
Table 16. Frequencies for Change in Basic Activities of Daily Living Items 
for Polio and Rheumatoid Arthritis 









No change  47 60 70 68 47 
Changed a little 33 26 30 19 33 
Changed a lot 20 14 18 13 20 









No change 65 58 67 70 65 
Changed a little 19 22 21 18 19 





 A review of the factor scales for increase in functional limitations found both similarities 
and differences between polio and RA. The BADL scales were similar for the two subgroups. 
The loadings of the IADL one factor scales were similar to RA except for change in medication 
management (.384 compared to .650). This lower value may be related to the number of 
medications that required management and the fluctuating character of RA. The RA sample took 
15% more prescription medications than the polio sample. Comparing mobility, the one factor 
solutions are extremely close. This speaks to the essential features of mobility. There is more 





VI. RESULTS:  MODEL TESTING 
 
 Higher rates of most health problems compared to same-age cohorts in the general 
population are reported by persons aging with physical disability. Using these AwD data, 
Campbell, Sheets and Strong (1999) compared frequencies of chronic conditions in a combined 
sample of individuals aging with polio, RA and stroke to population estimates of age-matched 
cohorts (45 – 64 year olds) from the 1994 National Health Interview Survey. Out of 17 
comparable chronic conditions, higher significant rates of chronic conditions were reported for 
all but two conditions, hearing loss and heart disease.  
 To examine frequencies between NHIS population estimates and these AwD subsamples 
of polio and RA, Fisher’s exact test was used to test whether there were differences in the 
frequencies of chronic secondary conditions between the AwD polio subsample and NHIS 
estimates, and AwD RA subsample and NHIS estimates for the same cohorts in the population at 
large using the 1994 National Health Interview Survey (NHIS). Chronic secondary conditions 
were used where there were comparable data in the NHIS. Two age cohorts were examined: 45 – 
64 year olds, and 65 years old and greater. Table 17 shows results of the frequencies between 
each subsample and NHIS estimate.  
 The younger middle-aged cohort of persons aging with physical disabilities reported 
higher rates of chronic secondary conditions. Those with RA in the younger cohort reported 
higher rates than those with polio in all categories but three, hearing loss, heart disease and 
stroke. The older 65+ cohort aging with physical disability reported higher rates as well, but not 
in as many conditions. Those with RA reported higher rates in three chronic secondary 
conditions. Polio reported two conditions. There is evidence of “accelerated aging” in these data 




Table 17.  Comparisons of Frequencies of Selected Chronic Health Conditions 
between Aging with Disability (AwD) Samples of Polio and Rheumatoid Arthritis 
and Age-Matched 45 – 64 year old and 65+ year old Cohorts from the 1994 
National Health Interview Survey (NHIS) 
  
AGE 45 – 64 COHORT 
 























   
   
Low vision  21**     31***   5 12   31***   8 
Glaucoma 2    7†   1   8 7   6 
Hearing Loss      15 16 14 24  50** 29 
Circulatory 
Disorders 
   
   
Heart Disease 18   8 14 28 28 33 
Hypertension    40**    42** 22  54* 47 36 
Stroke   7   1   2   4 10   6 
Endocrine 
Disorders 
   
   
Diabetes 15†  16*   6   6   28** 10 
Kidney Disease 7  10*   2   4  7   2 
Respiratory 
Disorders 
   
   
Asthma 15*   18**   5  15* 10   5 
Emphysema/COPD 6   11**   1  7   2   5 
       
†p<.1  *p<.05  **p<.01  ***p<.001 (p-values correspond to two-tailed Fisher’s Exact Test for 2x2 
table) 
 
A. Interrelationships Among Components 
 
 1. Polio 
For those aging with polio, increases in mobility limitations will be more strongly related 
to increases in functional limitations than to the number of chronic secondary health 
conditions, controlling for demographic and disability characteristics. 
 
 For those aging with polio, increases in mobility limitations predicts both increases in 




Consistent with this hypothesis, increases in mobility limitations, is a stronger predictor of 
increases in functional limitations (beta = .537) than of the number of chronic secondary health 
conditions (beta = .282). Results are contained in the final models in Table 19 (model 4) and 
Table 21 (model 5). 
 2. Rheumatoid Arthritis   
For those aging with rheumatoid arthritis, increases in symptoms (fatigue, pain and joint 
stiffness) will be more strongly related to increases in functional limitations than to the 
number of chronic secondary health conditions, controlling for demographic and 
disability characteristics.  
 
 The empirical evidence provides mixed support for this hypothesis. For those aging with 
rheumatoid arthritis, increases in fatigue (p<.05) and increases in pain (p<.05)  predicted increase 
functional limitations, but joint stiffness did not.  Neither increases in pain, fatigue or joint 
stiffness predicted number of chronic secondary health conditions.  Thus two of the three 
hypothesized predictors, increases in fatigue and pain, are more strongly related to increases in 
functional limitations than to the number of chronic secondary health conditions for persons 
aging with rheumatoid arthritis. Results are contained in the final models in Table 20 (model 4) 




B. Unique Disability Characteristics 
 
 1. Polio 
For those aging with polio, disability trajectory indicators (severity of initial onset, 
duration of disability and status at physical best) will be more strongly related to 
increases in functional limitations than to the number of chronic secondary health 
conditions controlling for demographic characteristics for individuals aging with polio.  
 
 None of the three trajectory indicators for polio, severity at onset, duration, and status at 
physical best, predicted functional limitations or number of chronic secondary health conditions. 
Thus, this hypothesis for polio was not supported. Results can be found in the final models in 
Table 19 (model 4) and Table 21 (model 5). 
 2. Rheumatoid Arthritis  
For those aging with rheumatoid arthritis, disability trajectory indicators (severity of 
initial onset, age at diagnosis and status at reference period) will be more strongly 
related to the number of chronic secondary health conditions than to increases in 
functional limitations controlling for demographic characteristics for individuals aging 
with rheumatoid arthritis. 
 
 None of the three trajectory variables for rheumatoid arthritis (severity of onset, age at 
diagnosis, and status at reference period) predicting the number of chronic secondary health 
conditions were significant.  Of the three predictors, only status at reference period (p<.05) 




arthritis. Detailed results appear in the final models in Table 20 (model 4) and Table 22 (model 
5). 
 C. Disability Bed Days 
 1. Polio 
For individuals aging with polio, increases in symptoms (pain, fatigue, muscle weakness), 
increases in mobility limitations and increases in functional limitations will be stronger 
predictors of the number of disability bed days in the last six months than will the number 
of chronic secondary health conditions, controlling for demographic and disability 
characteristics.  
 
 For those aging with polio, increase in fatigue (p<.05) and increases in functional 
limitations (p<.001) predicted the number disability bed days in the last six months whereas 
mobility limitations did not.  The number of chronic secondary health conditions did not predict 
the number of disability bed days.  Hence there was partial support for the polio subsample for 
this hypothesis. See the final model (model 6) in Table 23 for details. 
 2. Rheumatoid Arthritis 
For individuals aging with rheumatoid arthritis, the number of chronic secondary health 
conditions will be a stronger predictor of the number of disability bed days in the last six 
months than will increases in symptoms (pain, fatigue, joint stiffness) increases in 
mobility limitations and increases in functional limitations, controlling for demographic 





 For individuals aging with rheumatoid arthritis, the number of chronic secondary health 
conditions (p<.001) predicted the number of disability bed days in the last six months. Increases 
in symptoms and increases in mobility limitations did not predict the number of disability bed 
days in the last six months, but increases in functional limitations (p<.05) did.  For individuals 
with rheumatoid arthritis, partial support is found for this hypothesis. See the final model (model 
6) in Table 24 for detailed results. 
 D. Compare Disability Group Differences:  Pooled Sample Hypothesis 
 
 Based on measures available for those aging with polio and also those aging with 
rheumatoid arthritis, relationships between predictors and outcomes (controlling for 
demographic variables) will not consistently be stronger for either disability group.  This 
hypothesis applies to the common predictors of increases in chronic secondary health 
conditions (three predictors), increases in functional limitations (four predictors), and 
the number of disability bed days in six months (five predictors). 
 
 The prior six within-sample hypotheses addressed three domains (one in each domain for 
each subsample).  As a follow-up to the polio and RA hypotheses, a hypothesis is presented 
involving tests of interaction to determine the significance of differences between the models for 
the two disability groups.  This hypothesis offers a partial test of whether data on the two 
disability subsamples could be pooled.  There were, however, certain differences between the 
measures used to assess the relationships tested in the within-sample polio and RA hypotheses 
and the measures used in testing this between-sample hypothesis: the variables measuring the 




hypothesis tested outcomes one at a time, whereas the within-sample hypotheses included 
comparisons involving more than one outcome.   
  1. Interactions Between Disability Group and The Number Of Chronic  
   Secondary Health Conditions 
 
An analysis examined differences between the two disability groups in the strength of 
predictors.  Comparisons between the polio and RA subsamples were conducted by pooling the 
subsamples and testing for interaction. In separate regressions for each predictor, that is, the 
interaction between the predictor and a dichotomous measure of disability type (i.e., subsample) 
was tested.  Also included in the regressions for this analysis were three control variables (age at 
interview, gender and education).  The three disability trajectory variables for each sample 
(polio: duration, severity of initial onset and status at physical best; RA: age at diagnosis, 
severity of initial onset and status at reference period) were omitted because they were not 
equivalent across samples. 
In testing for group differences for predictors of the number of chronic secondary health 
conditions, the samples had three predictors common to both samples: increases in pain, 
increases in fatigue, and increases in mobility. None of the three predictors generated a 
significant interaction with disability group. The analyses produced no evidence that pain, 
fatigue or mobility was a stronger predictor of chronic secondary health conditions for one 



























































































































   


















   








































   


















   





























   




















   






























   

























   






















































   


















   




















   

























   





























   





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2. Interactions Between Disability Group and Functional Limitations 
 
 In the testing for group differences for predictors of increases in functional limitations, 
there were four predictors, common to both samples: increase in pain, increase in fatigue, 
increase in mobility, and the number of chronic secondary conditions. As mentioned above, in 
the final subsample models of the hierarchical regressions, two of these four predictors, increases 
in mobility (p<.001) and chronic secondary conditions (p<.05), were positively and significantly 
related to increases in functional limitations for the polio subsample, and all four predictors, 
fatigue (p<.05), pain (p<.05), increases in mobility limitations (p<.001) and number of secondary 
conditions (p<.05) were positively and significantly related to increases in functional limitations 
for the RA subsample. 
 Included in the regressions for the differential effects analysis were the three control 
variables (i.e., age, gender and education), but not the three measures of disease trajectory, which 
differed for the two subsamples. Two of the four predictors generated a positive significant 
interaction with disability group: increases in pain (p<.01) and in fatigue (p<.01).  These two 
regressions were rerun. Three of four common predictors (i.e., increase in pain, increase in 
fatigue, increase in mobility, number of chronic secondary conditions) were included as controls 
in addition to age, gender and education. The only significant interaction that remained was 
increases in pain (B for interaction term is .278; p<.05).  One significant result at p<.05 among 
12 tests of interaction is what would expect by chance alone, and this isolated significant result is 
likely to be a Type 1 error.  Refer to Table 18 for tests of interaction between disability samples 

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































3. Interactions Between Disability Group and Disability Bed Days in 
 Last Six Months 
 
  In the testing for group differences for predictors of the number of disability bed 
days in the last six months, there were five common predictors for both groups: increases in pain, 
increases in fatigue, increases in mobility limitations, number of secondary conditions, and 
increase in functional limitations. In the final subsample models of the hierarchical regressions, 
three of these five predictors were significantly related to number of disability bed days in the 
last six months for the polio subsample: increase in fatigue (p<.05), increase in mobility 
limitations (inverse relationship; p<.1) increase in functional limitations (p<.001). Two 
predictors were significant for the RA subsample: number of chronic secondary conditions 
(p<.001) and increase in functional limitations (p<.05). 
 Included in the regressions for the effect analysis were the three control variables (i.e., 
age, sex and education), but not the three measures of disease trajectory, which differed for the 
two polio and RA. None of the five predictors generated a significant interaction with disability 







































































































































































































































































































































































































































































































































































   

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































   
   
   
   
   
   
   
   




































































































































































































































































































































































































































































































































































































































































 This study investigated samples from two disability groups, individuals aging with post-
polio syndrome and rheumatoid arthritis. Six within-disability hypotheses and one between-
disability hypothesis were tested using a framework that conceptualizes disability trajectories 
within a life course perspective.  Exploratory factor analysis was used in scale development for 
three constructs of secondary conditions found in the hypotheses: increase in symptoms, number 
of chronic secondary health conditions and increase in functional limitations. Regression analysis 
was then conducted to test the six within-sample and one between-sample hypothesis using 
number of chronic secondary health conditions, increase in functional limitations and number of 
disability bed days in six months. The final models for polio and rheumatoid arthritis can be 
found in Figures 5 and 6 respectively. 
A. Within-Sample Hypotheses 
 
  1. Polio 
 In the first hypothesis, increases in mobility predicted both functional limitations and the 
number of chronic secondary health conditions. The stronger predictor was increases in 
functional limitations as opposed to the number of chronic secondary health conditions thus 
providing support for the hypothesis. Clinical literature is considerable with respect to the 
disease course of post-polio syndrome. Individuals who had recovered from polio have found in 
mid-life that they are having difficulty with new muscle weakness, pain and fatigue. These 
symptoms result in difficulty with balance and ambulation, and can result in wheelchair use. 
Wheelchair use can affect functional activities. Research regarding mobility is repeatedly found 




functional decline is inconsistent (Nollet, Beelen, Prins, de Visser et al., 1999; Stolwijk, Beelen, 
Lankhorst and Nollet, 2005).  
 The second hypothesis that the three trajectory variables (severity at onset, duration and 
status at physical best) would be more strongly related to increases in functional limitations than 
to the number of chronic secondary health conditions was not supported. Using the same dataset 
as this study, Sheets (1999) found similar results using disability trajectory variables for polio 
when looking at risk factors for decline in ADLs. The findings may be related to the way the 
disability trajectory component was constructed.  A possibility would be to break apart the 
trajectory variables.  Duration and severity of onset would stay together because the better 
represent the trajectory.  The status at physical best would then follow in the model.   
 The findings of the third hypothesis were partially supported. Increases in mobility 
limitations did not predict the number of disability bed days in the last six months, but fatigue 
and increases in functional limitations did. The number of chronic secondary conditions was not 
significant as hypothesized. The finding that increases in mobility limitations did not predict the 
number of disability bed days might indicate that individuals who have mobility limitations have 
adapted to them. For example, mobility with an assistive device from a cane to a walker to a 
wheelchair accomplishes the goal of getting around. However basic mobility may be to overall 
function, it is sometimes the easier to solve. Functional activities such as preparing food or 
performing light housework can be complex, require many tasks/steps to complete, and can 
prove more difficult to ameliorate. If one is having more difficulty performing tasks such as 
these, it is likely that they are experiencing more secondary symptoms that require bed days.   
  2.  Rheumatoid Arthritis 




supported. The first hypothesis predicting that increases in symptoms would be more strongly 
related to increases in functional limitations than to the number of chronic secondary health 
conditions was partially supported.  Increases in pain and increases in fatigue were significant, 
but not increases in joint stiffness, a characteristic symptom of rheumatoid arthritis. When 
increases in symptoms were first introduced in model 3 (Table 22), joint stiffness (p<.05) was 
significant. When increase in mobility limitations was added in model 4, the significance of 
increases in joint stiffness disappeared. Despite joints stiffness’ importance as a symptom to 
RA’s disease process, it has not shown up as a significant predictor, unlike pain and fatigue, in 
quantitative studies that have included symptoms. However, Lutze and Archenholtz’s (2007) 
findings in a qualitative study demonstrate the impact joint stiffness has on individuals aging 
with rheumatoid arthritis. The fact that increases in pain and increases in fatigue and not 
increases in joint stiffness were found to be significant for increases in functional limitations has 
support in the literature (McKenna and Wright, 1985; Hallet, Thyberg, Hass et al., 2003; Strating, 
Van Schuur and Suurmeijer, 2007) taking into account differences in study design. 
 The hypothesis predicting that the trajectory variables (severity of initial onset, age at 
diagnosis, status at reference period) would be more strongly related to number of chronic 
secondary health conditions than to increases in functional limitations. There was no support for 
this hypothesis as there were no significant variables for either outcome of number of chronic 
secondary health conditions or increases in functional limitations. In a prospective study, 
Navarro-Cano, del Rincon, Pogosian et al. (2003) found that disease severity in individuals with 
RA was significantly related to mortality, independently of comorbid disease. Furthermore, 
severity, disease duration, age, sex and comorbidity predicted mortality.  One explanation is that 




conditions. One reason for this was that combined subgroup analyses determined that there was 
not enough power to be analyzed separately. Secondly, it provided parsimony for causal 
modeling. This construct should be revisited with further analysis of individual mortality and 
morbidity secondary conditions.   
 The number of chronic secondary health conditions predicted disability bed days was 
partially supported. As hypothesized, however, increases in functional limitations also predicted 
disability bed day, when that wasn’t the expectation. Increases in symptoms and increases in 
mobility did not predict disability bed days. One could reason that the significant finding of 
increases in functional limitations was the result of increases in symptoms.  Pain and fatigue 
were found to predict functional limitations in the first hypothesis for RA and increases in those 
symptoms could be are contributing to the fluctuating nature of the disease process. However, as 
hypothesized, none of the symptoms of pain, fatigue or joint stiffness were significant. Fatigue 
(p<.05) was significant when it was first introduced in model 3 (Table 24). It’s significance, 
however, attenuated in model 4 and disappeared in model 5. 
 B. Between-Sample Hypothesis: Strength of Predictor-Outcome Relationships 
 
 Similarities are examined across samples in predictor-outcome relationships when 
interactions are not present.  The general pattern of positive relationships between predictor 
components (increase in symptoms, increase in mobility limitations, number of chronic 
secondary health conditions, and increase in functional limitations) and outcome (number of s, 
increase in functional limitations, and number of disability bed days) for both samples provided 
some evidence of the generality of the findings. 
 One hypothesis regarding sample differences in strength of predictors was tested with 




chance-based fluctuations in the data, a strategy for detecting interaction based on consistent 
patterns across predictors and outcomes was implemented.  The absence of a credible pattern of 
interactions indicates that large replicable differences in predictor-outcome relationships between 
the samples are unlikely.  More modest interaction effects, which may exist, could not be 
detected with the level of statistical power available. 
1.  Differences 
 Although there were significant predictor-outcome relationships for both disability 
groups, an analysis was required to examine the pattern of regression results for polio and RA to 
evaluate differential effect sizes across samples.  Such tests of interaction typically have low 
power.  To avoid treating chance-based fluctuations in the data as valid results, a strategy for 
detecting interaction based on consistent patterns across predictors and outcomes was 
implemented.  Evidence of interaction is strongest under the five conditions that follow.  
First, the differences between the effect sizes in the two disability samples for any given 
predictor and its outcome should be large.  Coefficients for increase in pain and increase in 
fatigue for RA were larger than the corresponding polio coefficients. However, the increase in 
mobility and chronic secondary health conditions subsample coefficients for polio and RA are 
similar in size.  This initial condition is not met.  
Second, for any predictor, at least the larger of the coefficients in the two samples should 
be significant.  This second condition was met for all four common predictors. 
 Third, the direction of the disability sample differences in predictor effect size should be 
consistent across predictors. In reviewing all four significant coefficients for RA, increases in 
mobility and number of chronic secondary health conditions are not directionally consistent with 




secondary health conditions coefficients are smaller than their polio counterparts while the RA 
increase in pain and increase in fatigue are larger than their polio counterparts.  Therefore the 
third condition is not met. 
 Fourth, the significant predictors should have coefficients in the expected directions, 
either positive or negative. Because all significant predictor coefficients are positively related to 
the outcome as hypothesized, this fourth condition is met.  
 Fifth, the interaction term (predictor x outcome) in the regression that tests for interaction 
should be significant. Both increases in pain and increases in fatigue produced significant 
interactions with disability group based on increases in functional limitations as the outcome 
variable. When a conservative approach is taken by adding the three other common predictors as 
controls in separate regressions for increases in pain and increases in fatigue, only increase in 
pain remained significant. Given the expected rate of type I errors, it is unlikely that increase in 
pain would be a replicable predictor of the outcome, increase in functional limitations. 
 In summary, only two of the five conditions that render interaction effects credible were 
met. The absence of a credible pattern of interactions indicates that large replicable differences in 
predictor-outcome relationships between the disability groups are unlikely. More modest 
interaction effects may exist, but could not be detected with the level of statistical power 
available. Considering the pattern of results and the limited number of common predictors that 
could be tested, a reasonable conclusion would be that the predictors do not operate differently 
for the two disability groups. More reliable estimates of predictor effects (and generalizable 
conclusions) for the pooled sample would have been possible if all predictors had been measured 
in the same way for the two disability groups. This is an example of one of the challenges of 




the disability groups and are key variables to the underlying conceptual framework of aging with 
disability and life course perspective. The trajectory variables anchor the disability temporally 
and account for the differences between polio and RA with respect to their disease courses. 
   2.  Similarities 
 When interaction is not present, examination of similarities across samples in predictor-
outcome relationships is considered. The general pattern of positive relationships between 
predictor categories (increase in symptoms, increase in mobility limitations, number of chronic 
secondary health conditions, and increase in functional limitations) and outcome categories 
(number of chronic secondary health conditions, increase in functional limitations, number of 
disability bed days) for both samples provided some evidence of the generality of the findings. 
 Increase in mobility (p<.001 for both subsamples) is a significant predictor of increase in 
functional limitations for both the polio and RA samples. This is consistent with some findings 
from literature (Shimada, Sawyer, Harada, Kaneya, Nihei et al., 2010; Kingston, Collerton, 
Davies, Bond et al., 2012). Loss of mobility may be one variable that can operate across 
disabilities. 
 Chronic secondary health conditions (p<.05 for both samples) is a significant predictor of 
increase in functional limitations in both subsamples. Chronic secondary health conditions’ 
placement in the Nagi/IOM framework is in the beginning of the model as secondary pathology. 
In this framework, it is not a direct effect to functional limitations as was in this analysis.   
 To summarize, two observations, common to both polio and RA, emerge from these data. 
First, increases in functional limitations predicts disability bed days.  Second, increases in 
mobility, the number of chronic secondary health conditions, and increase is symptoms (muscle 




Figures 5 and 6 contain the models for predicting chronic secondary health conditions, increases 
in function, and disability bed days. The beta coefficients and 95% confidence intervals are 













 C. Policy Implications 
  The within-sample analyses did yield partial results. The constructs that were 
significant for predicting number of disability bed days can give us some insight as to how policy 
could be considered. For instance, in the RA models, increases in functional limitations, the 
number of chronic secondary health conditions, and two of the three disability trajectory 
variables, age at diagnosis and severity at onset. All of these variables were positively associated 
with disability bed days except for age at diagnosis. Being younger when diagnosed with RA 
predicted more disability bed days. Backing up, one can then look at increases in functional 
limitations as the outcome. Increases in mobility limitations, number of chronic secondary health 
conditions, two symptoms (pain and fatigue) of the increases in symptoms component, and status 
at reference period all predict increases in functional limitations. Status at reference period 
negatively predicts functional limitations, therefore the more stable the disease process was at the 
last change in disease status, the more increases there were in functional limitations. Targeting 
those individuals who are younger, have more severity and who are having increases in 
symptoms (most likely pain and fatigue) for interventions before they are more likely to 
experience increases in secondary health conditions or increases in mobility limitations.  
 There are several ways to approach policy with the example above.  On a macro scale, 
reducing the number of disability bed days has implications for the workplace (from both the 
employer and employee perspective), controlling health care costs, reducing the impact of lost 
income, as well as the psychological factors associated with not being able to function optimally. 
Looking at the interrelationships among the predictors could inform the public health, aging and 
disability communities as to where to intervene with programs on individual, community, 




examined more closely as they can intensify the impact of these interrelationships. Finally, it can 
inform and educate those who are aging with, in this case, rheumatoid arthritis so that they can 
make the best choices for their circumstances.  
 D.  Limitations 
 The first limitation of this study is its use of self-report that is at risk for memory bias.  
Self-report is easy and inexpensive, however, they risk bias and inaccuracy due to over and 
under reporting in items such as functional limitations.  Other items, such as symptoms, are not 
subject to the same risk as they are intrinsically subjective. Only a respondent can assess severity 
of his or her pain.  
 With respect to diagnosis, there was no independent confirmation of being diagnosed or 
treated by a health care provider. Many individuals with polio were young when they were 
diagnosed and have relied on what others have told them for information about onset of and 
severity of their initial impairment.  
 There may be bias in accuracy of memory, especially when reporting changes over time, 
may result in exaggerated or diminished change. Memory is impacted by medication and 
individuals with disabilities are often on many medications, including those with RA. Symptoms 
such as pain and fatigue impact mood and could influence accuracy of reporting. In the future, 
introducing a limited number of performance measures such as pegboard test for fine motor and 
speed, picking up an object, lifting 10 pounds, gait speed, chair rise, and stair climb to the 
interview to supplement self-report would result in a more accurate assessment of limitations 
(Guralnik, 2011) and reduce the bias of the memory issues of self-report.  
 There are several measurement issues that are not optimal. The retrospective 




in severity of secondary conditions. The RA sample moves in and out of various levels of 
disability due to the fluctuating nature of the disease, thus this element of the disability trajectory 
is not illuminated. Due to the differences in disability trajectory, the measures of items across 
disabilities are problematic as they cannot be directly compared thus not all variables could be 
used.   
 Finally, subtraction-based change variables are sensitive to ceiling effects, that is, the 
most severe categories were less likely to change making interpretation of analyses difficult.   
 These data are nearly 20 years old. As discussed earlier in the dissertation, polio has been 
eradicated in much of the world.  As of 1989, there was an estimated 1.6 million individuals in 
the United States aging with Polio. The present population cohorts may be experiencing aging 
with disability differently.  Likewise, due to considerable advances in medication and surgery, 
those with RA will presumably “look” healthier than they were when these data were collected. 
 E.  Contributions 
 This study attempted to go beyond univariate and bivariate analyses by addressing 
conceptual and analytic gaps in the secondary conditions literature using a causal model to 
demonstrate how the components of secondary conditions --- increases in symptoms, increases in 
mobility limitation, chronic secondary health condition and functional limitations --- work 
together to affect a public health outcome. It has been established from clinical observation and 
anecdotally that secondary conditions do not work in isolation; they interact with one another. 
These analyses are an initial attempt to change the dialogue in the literature from conceptual to 
analytical by using scale development to create measures of secondary conditions and then using 




policy outcome while controlling for background factors and disability trajectory which takes 
into account aging and the life course perspective. 
F. Recommendations 
1. Research Methods 
 Further research to examine the measurable dimensions of disability will assist in 
creating comparable measures so that all predictors may be included and used across disabilities.  
This holds true in investigating within-disability similarities and differences. Even within 
disabilities, it is difficult to make comparisons.  In spinal cord injuries, for instance, individuals 
with the same level involvement may look very different in ADL limitations, for instance. An 
individual may have a complete or partial severation, or compression.  The implications for all 
aspects of secondary conditions measured in this study are often quite striking. Scientific 
development is essential to advancing the field. Three areas need to be pursued: analytic method, 
study design and scale development. 
 Analytic methods that can establish causal relationships and investigate patterns of 
change need to be explored. Linear regression analysis may not be the correct analytical method 
for specification of this study’s model. Other statistical methods, such as structural equation 
modeling may be more appropriate. Future research using longitudinal data, ideally panels, will 
likely improve study findings.   
 Addressing measurement and scale development is an essential consideration for better 
representing the multidimensional reality of what secondary conditions mean to aging with 
disability. There is a need to focus much more on how we construct composite analytic variables 
for components such as the ones in this study keeping parsimony in mind. It will be challenging 




“standardize” the types of secondary conditions before constructing and testing measurement 
models.   
  An additional consideration is the measurement of the outcome variable. This variable, 
number of disability bed days, may not have had the ability to capture any relationships between 
the constructs and outcome. Other public health policy outcome variables, such as health-related 
quality of life, number of physician visits, and participation, should also be tested with the same 
model. 
  2. Further Model Development 
 
 This model is a first step in going beyond the bivariate analyses found in the literature. 
The theory in the disability and secondary conditions field and how it relates to secondary 
conditions is developing. Contrasting this study’s methods and model against others will be 
valuable going forward for refinement.   
 One conceptual model (Rimmer, Chen and Hsieh, 2011) that could be used to further 
develop and shape this study’s model has two parts: the first is to systemically define secondary 
conditions and the second is to place secondary conditions within a clinical context that accounts 
for prevention interventions and policy implications. It does not look at interrelationships of 
secondary conditions as this model does. However, using Rimmer, Chen and Hsieh’s 
hierarchical algorithm to define secondary conditions could prove beneficial. The algorithm 
takes a medical or nonmedical condition and attempts to standardize individual secondary 
conditions by considering the timing, association, prevalence, treatment complication and risk 
factor in that order. As the steps progress, the potential secondary condition can be bounced from 
the decision tree as a pre-existing condition, associated condition, comorbidity or treatment 




with different components, and/or depending upon one’s disciplinary perspective, Rimmer, Chen 
and Hsieh’s approach attempts to be systematic and consistent.  
 Using the joint stiffness of rheumatoid arthritis, Rimmer, Chen and Hsieh’s algorithm 
discussed above is illustrated.  The temporal domain asks if the symptom occurs after the 
disability. In this case it does. Because of the slow development of the disease, it is also an 
indicator for diagnosing RA when two other symptoms are present:  pain on movement and 
tenderness in the affected joints are present. The joint stiffness continues after onset. The next 
domain is association, which asks if there is a direct association with the etiology or progression 
of the disability. In this case, yes.  The decision tree stops as joint stiffness is identified as an 
associated condition.  Another potential condition of RA is poor pulmonary function. Temporally, 
it occurs after the disability.  The association is not direct with the etiology or the progression of 
the disability. The next step asks if it is more prevalent in people with the disability. The 45 – 64 
year old cohort of persons with RA were found to have significantly (p<.01) more COPD when 
compared to a national age-matched cohort (see Table 16). Whether it is a treatment 
complication is the fourth consideration. Although medication could result in some pulmonary 
symptoms, it is not always. The final consideration is whether it is a medical or health condition 
risk factor, which it is. COPD meets all of these criteria as a secondary condition to RA. There 
are potentially gray areas for many secondary conditions when considering any of these steps in 
the algorithm. 
 Within a research context, the algorithm for identifying secondary conditions has great 
potential. A caveat, however, is the potential for labor intensive data collection to determine (if 




perfect, this is the first systematic attempt to take the art out of secondary conditions and 
introduce more rigor and parsimony.  
 Rimmer, Chen and Hsieh’s conceptual model is comprehensive, but complex. Its purpose 
is to understand the risk factors and consequences of secondary conditions in order to advance 
rehabilitation and health promotion research. Although this is not a conceptual model that 
addresses cross disability and aging, it does place secondary conditions within the clinical 
spectrum of medicine, rehabilitation, assistive technology, health promotion and public health. 
Starting with a primary disability, it identifies the onset and course of secondary conditions first 
via four non-modifiable antecedents: sociodemographic, pre-existing conditions, disability-
related, and associated conditions.  
 Secondly, it progresses to personal and environmental modifiable risk factors. The third 
and final section provides a framework for identifying the outcomes of secondary conditions on 
both individual and societal levels.  The model also acknowledges and provides for the range of 
prevention and intervention strategies from beginning to end of the model. Rimmer, Chen and 
Hsieh illustrate their conceptual model using the secondary condition of shoulder pain in an 
individual with spinal cord injury (SCI).  They use this illustration clinically. The challenge to 
cross disability research is the adaptation their model using aggregated data in targeted areas to 
develop constructs for modeling the interrelationships of secondary conditions and AwD with 
respect to a policy, or societal level, outcome. What Rimmer, Chen and Hsieh do not address is 
the disability trajectory and life course context. They hint at it in their non-modifiable 
antecedents domain, however. The disability trajectory and life course perspective is what makes 





 There has been little causal modeling using cross disability and aging data. This area of 
inquiry really isn’t yet at the theoretical stage. To the extent there is a theory, it rests on two 
central constructs: secondary conditions and aging with disability. These constructs are linked 
because of the trajectory variables, but should be built upon separately as well. Secondary 
conditions are real, occur in high frequencies and result in accelerated aging. Definitions have 
varied from researcher to researcher and are now emerging from a lengthy period of research 
inactivity. These analyses are a first attempt at addressing this lack of analytical modeling of 
secondary conditions within a semi-theoretical framework.  
 The limited findings do not support what is known from bivariate analyses and the few 
attempts to model very limited aspects of the problem. Judgment must be withheld with respect 
to the hypotheses, however. The analyses did not yield enough predictive strength to make 
comparisons possible across subsamples. Likewise, in examining similarities, only general, 
descriptive statements could be made. The fact that relationships between the components and 
the outcome were not demonstrated could be a matter of scale development and/or statistical 
techniques. Secondary analysis can be problematic as one must work with predefined measures 
and limited ability to create measures tailored to the analyses. With that said, the use of 
secondary analysis is not entirely culpable. Although the same measures were used for most of 
the variables, the difficulty arose when comparing disability groups. The correct measures were 
used for disability trajectory and symptoms variables as they are what is unique to the two 
disability groups, however, this results in not being able to use identical measures throughout the 




  The subjective nature of disability is an immense challenge in cross disability research 
for comparability within disabilities, across disabilities, across national studies, and across 
international studies which can present its own set of cultural problems and language barriers. 
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PARTICIPANT’S REMINDER CARD 
“Important Markers in Polio Timeline” 
 
Time of Initial Onset:  AGE:__________ YEAR:__________ _____DK 
 
Time of Initial Diagnosis: AGE:__________ YEAR:__________ _____DK 
(if different) 
 
Period of “Physical Best” 
 
AGES:  _________ to _________  _____DK _____N/A 
 
YEARS: _________ to _________  _____DK _____N/A 
 
Other Important Dates (Optional): 
 
Event: ____________________  AGE:________ YEAR:________ 
 
Event: ____________________  AGE:________ YEAR:________ 
PARTICIPANT’S REMINDER CARD 
“Important Markers in Rheumatoid Arthritis Timeline” 
 
When Diagnosed: AGE:__________ YEAR:__________ _____DK 
 
Current Status: (check one) 
 _____Remission  ______Good Period ______Bad Period _____DK 
 
Timing of Most Recent “Remission” or “Good Period”: ______DK _____N/A 
 
 AGE:  _________ to _________ 
 MONTH: _________ to _________  
 YEARS: _________ to _________  
 
Timing of Most Recent “Remission” or “Good Period”: ______DK _____N/A 
 
 AGE:  _________ to _________ 
 MONTH: _________ to _________  
 YEARS: _________ to _________  
 
Other Important Dates (Optional): 
 
 Event: ____________________  AGE:________ YEAR:________ 
 




APPENDIX II.  DESCRIPTION OF VARIABLES USED OR DERIVED FROM  






































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































APPENDIX III.  CORRELATIONS FOR MORBIDITY AND MORTALITY DIAGNOSES 
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